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Abstract 
The diversity of HIV-1 sequences derived from patients in Bushbuckridge, 
Mpumalanga, was investigated. The gag p24, pol p10 and p66/p51, pol p31 
and env gp41 gene fragments from 51 patients were amplified and 
sequenced. Quality control on the sequences was carried out using the LANL 
QC online tool. HIV-1 subtype was assigned using the LANL QC (RIP), REGA 
and jpHMM online tools. Subtype for the pol gene fragment was further 
designated using the SCUEAL online tool. Most of the sequences, that is 
89%, belonged to HIV-1 subtype C. LANL QC (RIP), REGA, jpHMM also 
detected recombinants in 11% of the sequences. One of the isolates could 
only have the env gp41 gene fragment amplified and sequenced, which was 
determined to be HIV-1 subtype B. Phylogenetic analysis using the Neighbor-
Joining and Maximum Likelihood methods from MEGA v 5 showed that, 
except for the env gp41 designated as a subtype B, all sequences in the study 
clustered with HIV-1 subtype C. Significantly, phylogenetic analysis showed 
that not only are the Bushbuckridge, Mpumalanga sequences related to HIV-1 
subtype C sequences from southern Africa, India, Ethiopia and Brazil, but it is 
possible there has been multiple introductions of HIV-1 in the province. 
SDRMs were observed in two samples. 
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CHAPTER ONE 
INTRODUCTION AND LITERATURE REVIEW 
INTRODUCTION 
Chapter one begins with an overview of the devastating public health impact 
of the HIV/AIDS pandemic. The subsequent sections seek to review the 
literature on aspects of HIV-1 relevant to the focus of the study, which is the 
phylogenetic analysis of HIV in Bushbuckridge, Mpumalanga. These aspects 
include the origins of HIV/AIDS; the biology of HIV including its taxonomy, 
morphology, genomic structure and replication, and the nature, causes and 
public health implications of HIV diversity. The literature review concludes with 
an examination of the molecular epidemiology of HIV both in South Africa and 
globally. The final section of Chapter 1 considers concepts and tools in HIV-1 
phylogenetic analysis. 
The HIV/AIDS pandemic 
By 2011 there were an estimated 34.2 million million people living with HIV. 
An estimated 2.5 million people had become infected with the virus and 1.7 
million people had died of HIV-related causes in 2011 alone (UNAIDS (2012) 
Report on the global Aids epidemic Geneva UNAIDS). Twenty five million 
people have died of HIV-related causes since the beginning of the epidemic. 
While Sub-Saharan Africa accounts for 11–12% of the world’s population, it is 
home to 68.7% of people living with HIV (Figure 1.1) (UNAIDS, 2012. Report 
on the global Aids epidemic Geneva UNAIDS). 
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Figure 1.1. Adults and children estimated to be living with HIV in 2011. (Source: 
UNAIDS, 2012). 
The HIV/Aids epidemic in South Africa 
South Africa, with an estimated 5.63 million South Africans living with HIV in 
2009, has the highest number of people living with HIV in the world, and 
almost one in five South African adults is HIV-positive. There has been a 
substantial decrease in AIDS related mortality with the annual number of AIDS 
deaths reduced from about 257,000 in 2005 to about 194,000 in 2010. 
Nationally, the HIV prevalence among women in the age group 30 - 34 years 
remains the highest with a prevalence of 42.6% in 2010. In 2008, HIV 
prevalence among women aged 20-24 was 21.1% compared to 5.15% in men 
aged 20-24 years. The prevalence of HIV in South Africa shows considerable 
variance across its nine provinces, with the highest HIV prevalence among the 
15-49 year olds in KwaZulu-Natal at 39.5% and the lowest Northern Cape at 
18.4% (South African Government, 2012). 
Bushbuckridge, Mpumalanga 
The Bushbuckridge Local Municipality is a predominantly rural area with a few 
small urban centres that include, Thulamahashe, Acornhoek, Marite, 
Dwarsloop and Mkhuhlu. The Bushbuckridge Local Municipality is situated in 
Stellenbosch University  http://scholar.sun.ac.za
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the Ehlanzeni District Municipality, which is in the north east of Mpumalanga 
Province, an area of the lowveld bordered by the Kruger National Park in the 
east, the Limpopo Province in the north and the Blyde River Canyon in the 
west. The population of Bushbuckridge is very poor, with only 14% of the adult 
population employed and over 85% of households living below the household 
subsistence level (HSL). Half of males and 14% of females between the ages 
of 25 and 59 are long-term migrant workers and represent a source of 
remittances, which comprise the largest proportion of the income of the 
population of Bushbuckridge (South African Government). 
The overall HIV prevalence in Mpumalanga in 2010 was 35.1%, slightly less 
than the 37.7% prevalence in Ehlanzeni District. The Gert Sibande District 
had the highest prevalence at 38.8%, and the Nkangala District had the 
lowest at 27.7% (South African Government, 2010). 
 
Figure 1.2. HIV prevalence distribution among antenatal women by district, 
Mpumalanga, 2010 (Source: South African Government, 2010). 
HIV prevalence in South Africa is characterized by extreme heterogeneity, 
both between and within provinces. There is, for example, highly uneven HIV 
prevalence between districts in the Western Cape Province, with districts 
comprising predominantly informal areas having the highest overall HIV 
Stellenbosch University  http://scholar.sun.ac.za
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prevalence (South African Government, 2007). There is also considerable 
variation in HIV prevalence amongst South Africa’s provinces, with KwaZulu-
Natal having the highest antenatal prevalence in 2005 at 39.1% and the 
Western Cape the lowest at 15.7% (South African Government, 2010). 
 
 
Figure 1.3. HIV prevalence distribution by province, South Africa 2010 (Source: 
South African Government, 2010).  
While the overall estimate of HIV prevalence in the general population in 
South Africa for 2010 was 17.9, the national HIV prevalence estimate among 
antenatal women in 2010 was 30.2% (South African Government, 2010). 
LITERATURE REVIEW 
1. The origins and history of HIV/AIDS 
In 1981 the Morbidity and Mortality Weekly Report (MMWR) of the Centers for 
Disease Control and Prevention (CDC) in the United States (US) reported 
cases of Pneumocystis carinii pneumonia, Kaposi’s sarcoma and T-
lymphocyte dysfunction in previously healthy young gay men and intravenous 
drug users (IDUs) in California and New York. When the CDC eventually 
Stellenbosch University  http://scholar.sun.ac.za
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defined the Acquired Immnune Deficiency Syndrome (AIDS) by 1982, a 
similar immunodeficiency had been recognized in persons with haemophilia A 
and heterosexual Haitians who had immigrated to the United States. The 
AIDS epidemic in Africa was not recognized until 1984. While the AIDS 
epidemiv in Europe was similar to the one in the Uited States in so far as it 
predominantly affected homosexual males, the epidemic in Africa replicated 
the situation with Haitian immigrants in the US and impacted mostly 
heterosexuals (CDC, 1981; CDC, 1982a; CDC, 1982b; Apetrei et al., 2004).  
In 1983 Barre-Sinoussi and her colleagues (1983) had isolated a retrovirus 
from the lymph node cells of a patient with lymphadenopathy and, 
accordingly, the virus was designated lymphadenopathy-associated virus 
(LAV). In 1986, a novel retrovirus similar to HIV, but also clearly different, was 
isolated from an immunocompromised individual in West Africa. The new 
retrovirus was initially called lymphadenopathy-associated virus-2, but its 
name was subsequently changed to HIV-2. this entailed that the aetiological 
agent of AIDS in the United States, Haiti, Europe, and central Africa should be 
renamed human immunodeficiency virus type 1 (HIV-1). HIV-2 is endemic in 
West Africa and has not spread pandemically, unlike HIV-1. HIV-2 is 
transmitted at lower rates than HIV-1. Further, HIV-2 infection produces lower 
plasma viral loads, causes AIDS in a lower percentage of patients, and has a 
longer incubation period (Apetrei et al., 2004).  
2. The HIV-1 virion and life cycle 
2.1 HIV taxonomy 
According to the classification system of the International Committee on the 
Taxonomy of Viruses (ICTV), HIV belongs to the genus Lentivirus, subfamily 
orthoretrovirinae, and family Retroviridae. The designation lentivirus is derived 
from the Latin word lentus, which means ‘slow,’ since lentiviruses differ from 
other retroviruses by their long latent period before the manifestation of 
clinical illness. Lentiviruses also differ from other retroviruses by their 
complicated genome structures (Wang et al., 2000). Classification of 
Retroviridae is based on the phylogenetic analysis of the most conserved 
Stellenbosch University  http://scholar.sun.ac.za
 8 
regions of reverse transcriptase (Coffin, 1999). Retroviridae is a family of 
single-stranded RNA viruses that utilize reverse transcriptase to synthesize 
DNA by using RNA as a template, which is then integrated into the genome of 
infected cells. Retroviridae are also diploid in that they possess two genomic 
RNA molecules per virion (Jetzt et al., 2000). According to the Baltimore 
system for the taxonomic classification of viruses HIV, as a single-stranded 
positive sense RNA virus with a DNA intermediate in its life-cycle, belongs to 
Group VI.  
Lentiviruses are characterized by the morphogenesis of the virion at the cell 
surface, the assembly of core components concomitantly with the budding 
process, and an elongated core comprising a core shell and the RNP nucleoid 
(Gelderblom et al., 1987). Lentiviruses also possess the ability to productively 
infect some types of non-dividing cells (Freed, 2001). By virtue of the fact that 
first, they utilize viral factors to regulate their expression, and second, they 
encode regulatory and accessory proteins essential to their life cycle, 
lentiviruses are described as complex retroviruses (Kuiken, et al., 2008). 
2.2 HIV morphology 
HIV-1 virions are spherical to pleomorphic in shape, 80 nm to 100 nm in 
diameter and possess a lipid bilayer envelope derived from the membrane of 
the host cell (Figure 1.4). The envelope contains 72 projections comprising 
the surface (SU) glycoprotein that is anchored to the lipid bilayer through 
interactions with the transmembrane (TM) glycoprotein. The lipid bilayer also 
contains several cellular membrane proteins derived from the host cell, 
including the major histocompatibility complex I and II (MHCI and II) proteins, 
and the intercellular adhesion molecule-1 (ICAM-1). 
 
Stellenbosch University  http://scholar.sun.ac.za
 9 
 
 
Figure 1.4. Structures of immature and mature HIV virions (Source: 
http://www.expasy.org/viralzone, Swiss Institute of Bioinformatics). 
 
A layer comprising the matrix protein MA is embedded in the inner surface of 
the lipid bilayer, and a conical-shaped capsid core comprising the capsid (CA) 
is located in the center of the virus. The capsid encloses two copies of the 
unspliced viral genome, which in turn is stabilized as a ribonucleoprotein 
complex through interaction with the NC. The capsid also contains protease 
(PR), reverse transcriptase (RT) and integrase (IN). Virus particles further 
enclose the accessory proteins, Nef, Vif and Vpr. Three additional accessory 
proteins that function in the host cell, Rev, Tat and Vpu, do not appear to be 
contained in the capsid (Briggs et al., 2003; Rubbert et al., 2007; Turner and 
Summers, 1999). 
2.3 HIV genome structure 
The HIV-1 genome (Figure 1.5) comprises a homodimer of linear, positive-
sense, single-stranded RNA that is 9.181 kb in size (Zhuang et al., 2002). The 
two RNA strands are capped, polyadenylated and noncovalently joined at a 
sequence near the 5' end of the genome known as the dimer initiation signal 
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(DIS). Lysine transfer RNA (tRNAlys3) is bound to the viral RNA in the viral 
particle and serves as a primer for reverse transcription.  
The basic, common structure of the provirus of primate lentiviruses is LTR-
gag-pol-vif-vpr-tat-rev-env-nef-LTR (Beer, Bailes, Sharp, Hirsch, 1999). The 
long terminal repeats (LTRs) contain elements that are involved in the 
regulation of the transcription of the provirus, including promoter sequences, 
and they comprise U3, R and U5 (unique 3′, repeat, unique 5′ sequence). The 
generation of the viral genomic RNA results in the loss of the promoter 
sequences at their 5′ ends (Hu and Temin, 1990; Ramírez de Arellano et al., 
2006).  
The gag, pol and env genes, from the 5' end - to the 3'-end, encode the major 
structural and non-structural proteins (Table 1.1). The gag gene encodes a 
polyprotein precursor whose name, Pr55Gag, is based on its molecular weight. 
Pr55Gag is cleaved by the viral protease (PR) to the mature gag proteins 
matrix (MA, p17), capsid (CA, p24), nucleocapsid (NC, p7) and p6. Two 
spacer peptides, p2 and p1, are also generated upon Pr55Gag processing.  
The pol-encoded enzymes are initially synthesized as part of a large 
polyprotein precursor, Pr160GagPol as a result of a rare frame-shifting event 
during the translation of Pr55Gag. Viral protease cleaves individual pol-
encoded enzymes, PR, reverse transcriptase (RT) and integrase (IN), from 
Pr160GagPol.  The envelope glycoproteins are also synthesized as a 
polyprotein precursor. Unlike the Gag and Pol precursors, which are cleaved 
by the viral PR, the Env precursor, known as gp160, is processed by a cellular 
protease during Env trafficking to the cell surface. The processing of gp160 
results in the generation of the surface (SU) Env glycoprotein gp120 and the 
transmembrane (TM) glycoprotein gp41. 
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Figure 1.5. HIV genome structure showing the open reading frames, genomic 
products and their cleavage sites, as well as sites for ribosomal framshift and 
alternative initiation (Source: http://www.expasy.org/viralzone, Swiss Institute of 
Bioinformatics). 
The tat and rev genes consist of two exons, with the second exon located 
within the env open reading frame. The other six HIV-1 genes have only one 
exon. Other accessory or auxiliary genes include vpu, vif, vpr and nef. The 
HIV genome also encodes several cis-acting elements, or control elements 
that are found adjacent to or near genes that they influence and that are 
involved in virion packaging, RT, RNA retention in the nucleus, RNA export 
and processing and transcription (Freed, 2001).  
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Table 1.1. HIV proteins, size and localisation in the virion  
                 (Source: Kuiken, et al., 2008)  
Name Size Function Localization 
Gag 
   MA 
     
    CA 
    NC 
 
p17 
 
p24 
p7 
p6 
 
Membrane anchoring; env interaction; nuclear  
transport of viral core (myristoylated protein)  
Core capsid 
Nucleocapsid, binds RNA 
Binds Vpr 
 
Virion 
 
Virion 
Virion 
Virion 
Pol 
   PR 
   RT 
RNase H 
   IN 
 
p15 
p66,p51 
p15 
p31 
 
Gag/Pol cleavage and maturation 
Reverse transcription, RNase H activity 
 
DNA provirus integration 
 
Virion 
Virion 
 
Virion 
Env 
    SU 
    TM 
 
gp120 
gp41 
 
Binds CD4 receptors and CCR5/CXCR4 coreceptors 
Fusogenic 
 
Plasma membrane/ 
Virion envelope 
Tat  p16/p14 Viral transcriptional transactivator Primarily in 
nucleolus/ 
nucleus 
Rev p19 RNA transport, stability and utilization factor 
(phosphoprotein) 
Primarily in 
nucleolus/ 
nucleus shuttling 
between  
nucleolus and  
cytoplasm 
Vif p23 Promotes virion maturation and infectivity Cytoplasm (cytosol,  
membranes) virion 
Vpr p10-15 Promotes nuclear localization of pre-integration complex, 
inhibits cell division, arrests infected cells  
at G2/M 
Virion nucleus 
(nuclear  
membrane?) 
Vpu p16 Promotes extracellular release of viral particles; degrades 
CD4 in the ER; 
Integral membrane 
protein 
Nef p27-
p25 
CD4 and MHC class I down-regulation  
(myristoylated protein) 
Plasma membrane,  
cytoplasm, (virion) 
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2.4 HIV life cycle 
2.4.1 Entry 
The HIV-1 life cycle is summarized in Figure 1.6. Viral entry into the cell is 
initiated by the binding of the SU glycoprotein, located on the viral membrane 
surface, to specific cell surface receptors. The major receptor for HIV-1 is 
CD4, an immunoglobulin (Ig)-like protein expressed on the surface of a subset 
of T cells and primary macrophages. Members of the G protein-coupled 
receptor superfamily of seven-transmembrane domain proteins, the α-
chemokine receptor CXCR4 and the β-chemokine receptor CCR5, also 
function as coreceptors for HIV entry.  
 
 
Figure 1.6. Replication cycle of HIV (Source: http://www.expasy.org/viralzone Swiss 
Institute of Bioinformatics). 
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The HIV envelope protein exists as a homotrimer composed of three non-
covalently associated heterodimers of the gp120 (surface, SU) and gp41 
(transmembrane, TM) subunits on the membranes of both HIV virions and 
productively infected cells (Garber et al., 2004).  
The interaction between the gp120 of the virion and the CD4+ receptor and α-
chemokine or β-chemokine coreceptors on the target cell induces the two 
heptad repeat motifs of the gp41 ectodomain to form a six helical bundle, 
which facilitates fusion between the viral envelope and cell membrane. The 
membrane fusion reaction between the lipid bilayers of the viral envelope and 
the host cell plasma membrane enables the viral core to gain access to the 
cytoplasm of the target cell and is thus central to the infection process (Freed, 
2001). 
2.4.2 Reverse transcription 
HIV, as a member of the Retroviridae family, utilizes reverse transcriptase to 
convert genomic RNA into complementary DNA as part of its replication 
process. HIV-1 RT is an asymmetric heterodimer composed of p66 and p51 
subunit. The p51 polypeptide is derived from the p66 by proteolytic cleavage 
of its C-terminal RNase H domain. The p66/p51 HIV-1 RT heterodimer 
contains one DNA polymerization active site and one RNase H active site, 
which both reside in the p66 subunit at spatially distinct regions, while the p51 
subunit fulfils a structural function. 
Cellular tRNAlys3 binds to the genome of HIV-1 at the primer binding site 
(PBS) to initiate the synthesis of the minus (–) DNA strand, and 
simultaneously the RNA strand is digested by RNase H. The PBS is near the 
5′ end of the genome and degradation of the RNA by RNase H allows DNA 
synthesis to be transferred to the 3′ end of the RNA. After strand transfer, (–) 
strand synthesis continues accompanied by RNase H degradation of the RNA 
genome which does not proceed to completion. The purine-rich polypurine 
tract (PPT) is resistant to RNase H cleavage and serves as the primer for plus 
(+) strand synthesis. The PPT sequence is just 5′ of U3. Removal of the PPT 
primer by RNase H defines the left end of the upstream long terminal repeat 
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(LTR), which, together with the downstream LTR, is the substrate for the viral 
integrase enzyme that inserts the linear viral DNA in the host genome 
(Sarafianos, et al., 2001; Sarafianos et al., 2004). 
2.4.3 Integration 
The ability of lentiviruses to infect nondividing cells stems from lentiviral 
nucleophilic proteins that allow the viral cDNA to translocate through the 
nuclear envelope in a nondividing cell. The IN catalyzes the insertion of the 
linear, double-stranded viral DNA into the host cell chromosome. The 
integration of the viral DNA into the host cell chromosome generates a 
“provirus”, which behaves essentially as a cellular gene (Craigie and 
Bushman, 2012; Freed, 2001). 
2.4.4 Transcription 
The transcription of the provirus into both the genome and mRNA molecules 
completes the HIV replication cycle. The HIV-1 LTR is the site of 
transcriptional initiation and contains cis-acting elements required for RNA 
synthesis. The LTR comprises three regions: U3, R and U5 and transcription 
initiates at the U3/R junction while U3 contains an array of elements that direct 
the binding of RNA polymerase II (RNA Pol II) to the DNA template including a 
TATA element, to which transcription factor IID binds. 
Rev and the RRE, a large, highly structured RNA element located in the env 
gene and present in all unspliced and partially spliced HIV-1 RNAs, cooperate 
to transport unspliced and partially spliced RNAs from the nucleus to the 
cytoplasm. Unspliced viral RNAs function as the mRNAs for the Gag and 
Gag-Pol polyprotein precursors, and are packaged into progeny virions as 
genomic RNA, and partially spliced mRNAs encode the Env, Vif, Vpu, and Vpr 
proteins (Freed, 2001). 
2.4.5 Assembly 
The assembly of lentiviruses, including HIV-1, takes place at the plasma 
membrane of the infected cell. The final step in the process of virus assembly 
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and release involves the pinching off, or budding, of the virus particle from the 
host cell plasma membrane. During, and immediately following the release of 
the virus from the plasma membrane, the viral PR cleaves the Gag and 
GagPol polyprotein precursors to generate the mature Gag and Pol proteins. 
Following cleavage, CA forms a conical shell around the RNA/protein complex 
inside the core (Freed, 2001; Sundquist and Kräusslich, 2012). 
3. HIV-1 diversity 
HIV is characterized by extreme genetic variability. The first cause of this 
extraordinary genetic heterogeneity is the result of the multiple introductions of 
genetically diverse simian viruses into human (Hahn et al., 2000). A system 
that is currently widely used for classifying HIV-1 and HIV-2 into a number of 
subtypes is based primarily on genetic sequences coding for the envelope 
(env) and structural (gag) proteins and methods to infer the phylogenetic 
relationships between them (Hu, et al., 1996). 
The following criteria were laid down for the current classification system into 
subtypes: subtypes are approximately equidistant from one another in env; 
the env phylogenetic tree is for the most part congruent with the gag 
phylogenetic tree; and two or more samples are required to define a new 
sequence subtype (Janssens et al., 1997). The identification of these 
subtypes and CRFs is important in epidemiological tracking and in the 
understanding of the ever-changing epidemic (Skar et al., 2011). 
3.1 HIV-1 groups M, N, O and P 
HIV-1 and SIVcpz lineages are intermingled within the evolutionary tree, 
defining three distinct groups of HIV-1, M, N, O and P, each of which must 
have arisen from a separate cross-species transmission (Figure 1.7). African 
primates are infected by simian immunodeficiency viruses, and the two major 
viral types infecting humans, HIV-1 and HIV-2, represent zoonotic 
transmissions from two different primates, Pan troglodytes troglodytes 
(chimpanzees) (Gao, et al., 1999) and Cercocebus atys (sooty mangabeys) 
(Gao, et al., 1992), respectively. HIV-1 groups M and N originate directly, but 
independently, from SIVcpz found in the chimpanzee Pan troglodytes 
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troglodytes in West-Central Africa. HIV-1 group O and group P are related to 
SIVgor identified in gorillas (Gorilla gorilla gorilla) in Cameroon (Gao et al., 
1999; Hahn et al., 2000; Hemelaar, 2012; Keele, et al., 2006; Plantier, et al., 
2009; Takehisa, et al., 2009; Vallari, et al., 2011; Van Heuverswyn, et al., 
2006). 
 
Figure 1.7. Phylogenetic tree of SIV and HIV-1. Phylogenetic tree based on 
polymerase sequences of reference sequences of SIV and HIV-1.  
(Source: Hemelaar, 2012). 
3.2 HIV-1 subtypes, CRFs and URFs 
HIV-1 groups have spread very unevenly and the global AIDS pandemic is 
largely the result of HIV-1 group M. Since its advent in the human population, 
the HIV-1 group M has undergone rapid diversification. The M group is 
classified into various subtypes, inferred from the “starburst” radiation from the 
root of the group M evolutionary tree, which seem to have arisen from 
incomplete sampling, local founder effects, as well as the exponential growth 
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of the number of infected individuals (Figure 1.8) (Hahn et al., 2000; Rambaut 
et al., 2001; Sharp, 2002).  
 
Figure1.8. HIV-1 group M diversity. Phylogenetic relationships among subtypes, 
sub-subtypes and CRFs based on env sequences (V2-V5) of HIV-1 isolates sampled 
worldwide. Strains are color-coded according to their geographical origin. DRC 
samples are coded separately since they are more diverse than all the strains 
sampled worldwide. (Source: Butler et al., 2007). 
Founder effects involved in the spread of HIV-1 infection have resulted in the 
uneven distribution of M group strains among geographic areas and exposure 
risk populations. This accounts for the fact that HIV-1 strains tend to exhibit 
specific associations with particular geographic regions and/or modes of 
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transmission (Gifford, et al., 2007). HIV-1 phylogenetic classification is 
summarized in Table 1.2. Subtypes are genetically defined lineages that can 
be resolved through phylogenetic analysis of the HIV-1 M group as well-
defined clades, or branches, in a tree (Gaschen, et al., 2002). The HIV-1 
subtypes are approximately equidistant evolutionary relationship, except for 
subtypes B and D (Sharp et al., 1999). 
Currently, strains belonging to the same subtype can differ by up to 20% in 
their envelope proteins, and between-subtype distances can soar to 35% 
(Gaschen, et al., 2002). Within a subtype, variation at the amino acid level is 
in the order of 8-17% but can be as high as 30%, whereas variation between 
subtypes is usually between 17% and 35% but can be up to 42%, depending 
on the subtypes and genome regions examined (Hemelaar, 2012). These 
subtypes differ from one another by an average nucleotide percentage 
distance of 27%. And within each subtype, there is a plethora of HIV-1 
variants that represent expressions of intra-subtype diversity with average 
nucleotide distances approximately 11% (Janssens et al., 1997). 
Recombination occurs frequently, and a CRF carries sections of two or more 
subtypes in a mosaic genome; a recombinant lineage is designated a CRF 
when related forms are found in multiple epidemiologically unlinked individuals 
(Table 1.2). 
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Table 1.2. Phylogenetic classifications of HIV-1 (Source: Taylor et al., 2008). 
Classification Definition Examples 
Subtypes or 
clades 
Genetically related HIV-1 strains that are 
essentially phylogenetically equidistant, generating 
a starlike, rather than a treelike, phylogeny. 
Subtypes A, B, C, D, F, G, H, 
J, and K are currently known; 
A through D are highly 
prevalent, others have low 
prevalence and limited 
geographic distributions 
Sub-subtypes Distinct lineages within a subtype; genetic distance 
between sub-subtypes is smaller than that between 
subtypes 
Subtypes A and F are 
subdivided into subsubtypes 
A1 through A4 and F1 and 
F2, respectively; mostly these 
circulate in Central and West 
Africa 
Intersubtype 
recombinant 
forms 
Mosaic strains with segments from two or more 
subtypes alternating across the genome 
Common in mixed-subtype 
epidemics; thought to result 
from infection of a person with 
more than one HIV-1 
subtype 
Circulating 
recombinant 
forms 
Specific recombinant forms that are spreading in a 
population; new forms are defined when three 
people without direct epidemiologic linkage are 
found to be infected; the assigned name reflects 
sequence of discovery and subtype composition, 
with “cpx” indicating forms containing three or more 
subtypes 
Currently, 51 forms are 
described; 
CRF01_AE and CRF02_AG 
are found principally in 
Southeast Asia and West 
Africa, respectively; others 
have more limited 
distributions 
Unique 
recombinant 
forms 
Intersubtype recombinant forms recovered from 
only a single person 
Hundreds of forms have been 
described on the basis of 
partial or complete genome 
sequences; their potential for 
epidemic spread is unknown 
Second 
generation 
recombinants 
Some CRFs have recombined further with other 
subtypes or CRFs giving rise to SGRs 
 
Geographically 
distinct 
lineages 
Lineages, often country-specific, that are 
distinguishable phylogenetically; unlike 
subsubtypes, they are not phylogenetically 
equidistant within subtypes 
Thai B, Indian C, West vs. 
East African D, and Former 
Soviet Union A (FSU-A) 
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3.3 The origins and causes of HIV diversity 
3.3.1 High rate of replication and rapid viral turnover. 
The estimated average total HIV-1 production is 10.3 x 109 virions per day. 
The minimum duration of the HIV-1 life-cycle in vivo is 1.2 days on average, 
and the average HIV-1 generation time – defined as the time from release of a 
virion until it infects another cell and causes the release of a new generation 
of viral particles – is 2.6 days (Hoet al., 1995; Perelson et al., 1996; Wei, et 
al., 1995)  
3.3.2 The low fidelity of HIV RT 
The HIV-1 reverse transcriptase enzymes are encoded by viral pol gene and 
use either a DNA or RNA template and, like all RNA polymerases, lack the 
3'→5' exonucleolytic proofreading activity. Estimates of error rates during 
polymerization in vitro range from one error in every 102 to one error in every 
107 nucleotides polymerized (Preston and Dougherty, 1996). The mutation 
rate of HIV-1 in this system was determined to be more or less 3.4 x 10-5 
mutations per base pair per replication cycle (Mansky and Temin, 1995). Thus 
the misincorporation, deletion, insertion, or duplication of nucleotides arising 
from the reverse transcriptase’s lack of 3'→5' exonucleolytic activity has been 
estimated to occur at a frequency of 10-4 to 10-5 (Malim and Emerman 2001). 
The most commonly detected mutations were base substitution mutations, G 
to A and C to T transition mutations, and frameshift mutations, -1 frameshifts 
in runs of T's and A's, (Mansky and Temin, 1995). 
3.3.3 Viral quasispecies 
The notion of viral quasispecies seeks to describe the extensive genetic 
variation that characterizes populations of RNA viruses. Thus viral 
quasispecies represent discrete ensembles of viral genomes defined in time 
and space (Vartanian et al., 1994). The diversity of viral quasispecies is 
shaped by a combination of mutation and selection forces. The main selective 
forces that have been proposed to drive HIV diversity are the immune 
response, cell tropism, and random activation of infected cells (Bonhoeffer et 
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al., 1995). The quasispecies model for RNA viruses predicts the existence of 
a replication error threshold beyond which there is a melting or total loss of 
sequence information. The retroviral G to A hypermutation is probably an 
example of this replication error. The G to A transitions within GpA may result 
from temporary dislocation of the primer and template strands by a single 
base. The two circumstances may be related by the local dCTP substrate 
concentration. G to A hypermutation is an example of induced mutation 
whereby the viral reverse transcriptase is forced into making errors by 
imbalances in the intracellular dCTP concentration (Vartanian et al., 1994). 
3.3.4 Recombination 
Two copies of viral RNA are encapsidated in HIV-1 virions, and the two 
genomes can be genetically distinct if the cell producing the virus has been 
infected with two or more different viruses. During the ensuing replicative 
cycle, the alternate use of the two templates RT produces a recombinant DNA 
genome that is different from that of either parental strain. Extensive studies 
performed in vitro have shown that recombination occurs frequently 
throughout the genome during HIV replication (2 to 20 
events/genome/replicative cycles) and can efficiently shuffle closely linked 
genetic markers. In vivo, recombination between viral variants also occurs at a 
high rate, reflecting the frequent occurrence of cells dually infected by 
genetically distinct HIV variants (Nora et al., 2007). Genetic analyses have 
shown that recombination occurs mainly during minus-strand DNA synthesis, 
which supports these models for recombination. In order for novel 
recombinants to be generated, the two RNAs packaged in the virion must be 
genetically different (heterozygous virions). Only cells infected by more than 
one retrovirus (double infection) can produce heterozygous virions; therefore, 
how often double infection occurs affects the overall frequency of 
recombination (Chen, et al., 2005; Hu and Temin, 1990). 
Recombination among these highly divergent strains contributed further to the 
extensive diversity of the virus observed in Central Africa. For example, 
possible recombination events were first detected when phylogenetic 
analyses of isolates differed by which gene or region within the same gene 
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was used for analysis (Hu, et al., 1996; Louwagie, et al., 1993; Nkengasong, 
et al., 1994; Paraskevis and Hatzakis, 1999). 
4. Public health implications of HIV diversity 
4.1 HIV diversity and mode of transmission 
The first HIV-1 isolates were derived mostly from men who have sex with men 
and injecting drug users in North America and Western Europe, while HIV-1 
subtype distribution among the heterosexual population in other regions of the 
world tended to be genetically diverse (Tatt et al., 2001). Studies of subjects 
from Thailand, the Netherlands, Brazil, Russia, Denmark, Argentina and 
Australia have demonstrated that individuals from different risk groups are 
infected by distinct populations of HIV variants (Learn, and Mullins, 2003). A 
study found that patterns of HIV-1 genetic diversity could be explained to 
some extent by the risk factors of MSM and IDU/IDX (Anderson et al., 2003). 
A subtype might initially predominate in a specific transmission group but 
there is little supporting evidence to suggest that subtypes A, B, C, D and 
CRF01_AE are any more or less transmissible by a specific route, in a 
specific ethnic group or in specific cell types. In addition, such initial 
predominance is generally lost during an epidemic. For example, in Thailand 
HIV-1 subtypes B and CRF01_AE were segregated to intravenous drug users 
and heterosexuals, respectively, in the late 1980s but are now more uniformly 
mixed in the Thai population (Ariën et al., 2007). A study did not consider 
race, gender, or risk factors for the selection of the local controls because of a 
lack of evidence suggesting a correlation between these factors and specific 
HIV-1 DNA sequences (Metzker et al., 2002). 
4.2 HIV diversity, rate of transmission and pathogenesis. 
The uneven distribution of HIV-1 subtypes in different regions of the world 
does not necessarily stem from the inherent properties of the viral strains 
themselves but may arise from founder effects in which ne or more subtypes 
are introduced and consequently established in a population before other 
subtypes. The suggestion that virological factors such as HIV-1 subtype can 
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determine patterns of transmission and disease progression in different 
regions of the world amounts to an ‘ecological fallacy’, or inferring individual 
risk from apparent associations at the population level. Differences and 
changes in subtype distribution in different populations are ecological and do 
not reflect incontrovertible evidence for differences in transmissibility between 
the various subtypes (Hu, et al., 1996). 
There were no significant differences found in the rate of disease progression 
or in the rate of CD4 lymphocyte decline between individuals infected with 
subtypes A, B, C or D. And it was found that Israeli men infected with HIV-1 
subtype B and Ethiopian immigrants infected with HIV-1 subtype C displayed 
similar rates of CD4 lymphocyte decline. This despite the fact that the CXCR4 
positive, SI phenotype, a biological phenotype that has been associated with 
an increased risk of rapid disease progression among individuals infected with 
subtype B, is rarely found among subtype C isolates (Alaeus et al., 1999; 
(Ariën et al., 2007). Despite the fact that the 32-base pair deletion in the 
CCR5 gene, which has been reported to be associated with a favourable 
outcome after HIV-1 infection, has an allelic frequency of approximately 10% 
in Caucasians and is virtually absent in Africans, it was found that there was 
no difference in the rate of disease progression between ethnic Africans and 
ethnic Swedes (Alaeus et al., 1999). 
There are subtype-dependent differences in coreceptor usage in which 
CXCR4-positive isolates were rare in subtype C and dual tropism for CXCR4 
and CCR5 was rare among subtype D isolates. While, subtype-C-infected 
individuals did not differ from other individuals in clinical or immunological 
status, there is the possibility that subtype-specific difference in the correlation 
between biological phenotype and CXCR4 usage may have implications for 
biological properties such as virulence, tissue tropism, or transmissibility 
(Tscherning et al., 1998). HIV-1 subtype D may be more pathogenic than 
subtypes A and C and recombinant viruses. The reason subtype D may be 
more pathogenic compared to other subtypes could be because subtype D 
has a dual coreceptor tropism, both CCR5 and CXCR4, unlike subtypes A and 
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C which only express tropism for CCR5 (Baeten, et al., 2007; Huang et al., 
2007; Kiwanuka et al., 2008; Vasan, et al., 2006). 
HIV-discordant couples in which the initially HIV negative partners were 
monogamous were found to have a statistically significant higher rate of HIV 
transmission for subtype A viruses relative to subtype D, which may be due to 
the differences in coreceptor tropism between the two subtypes (Huang et al., 
2007; Kiwanuka et al 2009). There were also significant differences in the 
distribution of in utero transmission time found between HIV-1 subtype C env, 
subtype A env, and subtype D env (Renjifo et al., 2004). 
4.3 HIV diagnostics and management 
Genetic diversity poses a serious challenge for HIV-1 testing, diagnosis and 
monitoring (Butler et al., 2007). 
4.3.1 Diagnostics 
The majority of HIV serological diagnostic tests were developed using HIV-1 
subtype B. The third and fourth generation serological diagnostic tests can 
detect both antigens and antibodies. While many third and fourth generation 
serological tests are sensitive to HIV-2, group O and most group M subtypes, 
false negatives have been observed with HIV-1 subtype D. The fact that third 
and fourth generation tests can detect early has, however, produced varying 
results among clades. And it has been observed that CRF01_AE has a 
significantly longer “early” window period with these fourth generation 
serological tests than subtype B. These third and fourth generation serological 
diagnostic tests for the p24 antigen tests showed 98.1% sensitivity with HIV-1 
subtype C (Butler et al., 2007). The fact that HIV rapid diagnostic tests (RDTs) 
also tend to be based on antigens from HIV-1 subtype B may impact on their 
ablity to detect diverse HIV-1 and HIV-2 subtypes circulating regionally, as 
well as within patient recombinant and dual infections. But one study found 
that the OraQuick HIV-1/2 RDT (OraSure Technologies, Inc., Bethlehem, PA) 
effective in detecting isolates from Kinshasa, DRC.  A study to determine the 
sensitivity of 6 HIV-1/HIV-2 rapid screening tests in comparison to other HIV 
diagnostic tests, including a third generation EIA, using a well characterized 
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panel of HIV sera derived from HIV-1 groups M and O, HIV-2, as well as serial 
samples from two primates experimental primary SIV infection to mimic HIV-2 
seroconversion samples, found that the rapid tests only became positive 2 to 
8 days later than the third generation EIA (Makuwa, M. et al., 2002; Shott et 
al., 2012). 
4.3.2 Management 
Monitoring viral load (VL) or the quantification of HIV-1 RNA in serum or 
plasma is used to determine disease progression and response to treatment 
is important in the clinical management of HIV (Butler et al., 2007, Swanson et 
al., 2003). Nucleic acid-based assays for the detection and monitoring of viral 
load involve the amplification of a HIV-1 target region and detection using 
sequence-specific probes. Sequence polymorphism in primer and probe 
binding regions can lead to the underestimation or even failure to detect RNA 
from some HIV-1 subtypes, strains or isolates (Sizmann et al., 2010; Swanson 
et al., 2003). 
There are several methods of determining VL, including real-time PCR (RT-
PCR) (Amplicor, Roche), branched DNA assays (bDNA, Bayer), nucleic acid 
sequence based amplification (NASBA, Vironostica) and ligase chain reaction 
(LCR, Abbott). The fact that early VL assays were designed for HIV-1 subtype 
B meant, since real-time-PCR depends on specific primers, they often could 
not detect non-B subtypes, particularly A, CRF01_AE and F (Butler et al., 
2007).  
A study found that among individuals infected with CRF02-AG strains the 
sensitivity and average viral load values were significantly lower for the 
NucliSens assay (Organon Teknika, Boxtel, the Netherlands) than for the 
Amplicor HIV-1 Monitor (version 1.5; Roche Diagnostics, Branchburg, NJ, 
USA) and the Versant HIV-1 RNA (Bayer, Cergy Pontoise, France). The HIV 
monitor assay and the NASBA assay appear unable to accurately quantify 
HIV-1 RNA levels in plasma samples from many individuals infected with 
subtype-A, which may stem from primer mismatches (Alaeaus, et al., 1997). 
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The NucliSens HIV-1 QT assay (bioMerieux), NASBA, misses subtypes G and 
A, and may underestimate Group O (WHO/UNAIDS 2007).  
4.4 HIV diversity and antiretroviral therapy and drug resistance 
HIV-1 subtype differences do not impact the response to antiretroviral 
therapy.The drug susceptibility testing of subtype A, B, C, and E isolates 
revealed that the non-B isolates were also similarly inhibited by 
azidothymidine (AZT), lamivudine (3TC), didanosine (ddl), ritonavir and 
nevirapine (Palmer et al 1998). No association was found between HIV-1 
subtype and virologic response to antiretroviral therapy in HIV-1-infected 
children (Jülg, and Goebel, 2005). Isolates derived from different HIV-1 
subtypes, including G, C, A, J, D, and F, were all found to be susceptible to 
protease inhibitors (Holguín et al., 2004). HIV-1 subtype C isolates from 
Zimbabwe were found to be all found to be susceptible to antiretroviral drugs 
(Shafer et al, 1999). 
HIV subtypes can take different pathways in evolving resistance to 
antiretroviral drugs (Grossman, et al 2004a, Johnson et al., 2010). Mutations 
in the HIV-1 subtype B reverse transcriptase that arise in the presence of 
zidovudine or stavudine, the thymidine analogue-associated mutations or 
TAMs, involve alternate, mutually exclusive, pathways, designated TAM1: 
M41L, T215Y, L210W, D67N, and TAM2: D67N, T215F, K70R, K219QEN. 
However, HIV-1subtype C-infected adults treated with first line ZDV/ddI-
containing HAART in Botswana, the 67N 70R 215Y genotype was the 
dominant pattern of NRTI-associated mutations at the time of virologic failure. 
It is possible that the 67N, 70R, 215Y genotype represents a unique TAM 
pathway among HIV-1 subtype C-infected individuals treated with ZDV/ddI-
containing HAART as the first line regimen (Novitsky et al., 2007). The M41L 
and L210W mutations, as well as the T215Y mutation, occurred at a much 
lower prevalence in patients infected with non-subtype B HIV-1 isolates, 
particularly subtypes A1, A2, C, F1, F2 and CRF06_cpx, than in HIV-1 
subtype B isolates (Montes et al., 2004). 
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HIV-1 subtype C reverse transcriptase possesses the valine polymorphism 
GTG at codon 106, which occurs in 94% of subtype C isolates but only in 
1.5% of subtype B variants. The GTG polymorphism favours the occurrence 
of a V106M, or GTG→ATG, mutation following either in vitro or in vivo 
exposure to efavirenz (EFV) (Brenner et al., 2003). Exposure to EFV can also 
select the V106M mutation in subtypes/CRFs other than C, for example 
CRF02_AG (Montes et al., 2004). The V106M mutation rarely appears in 
subtype C patients treated with NVP (Grossman, et al 2004b; Morris et al., 
2003). 
There was more prevalence of nucleoside analogue-associated mutations or 
NAMs in HIV-1 subtype B-infected patients, while NNRTI resistance-
associated mutations seemed to accumulate more rapidly in HIV-1 subtype C 
patients, in which they display a unique pattern. However, the M184V 
mutation seems to occur at equal frequencies in both subtype B- and subtype 
C-infected patients (Grossman et al., 2004b). 
The D30N mutation in the HIV-1 protease occurs much less frequently in HIV-
1 subtype C than in subtype B. The D30N mutation is a primary nelfinavir 
mutation, in contrast to the L90M mutation, which confers cross resistance to 
protease inhibitors including nelfinavir, indinavir and saquinavir. The D30N 
and L90M mutations are rarely selected on the same isolate, and in the 
majority of subtype-B-infected patients developing resistance after failing 
nelfinavir as their first PI, the D30N mutation is selected, while the L90M 
mutation or other primary mutations are selected in a significantly smaller 
proportion (Grossman, et al 2004a, Johnson et al., 2010). 
The M36I mutation is a secondary resistance mutation to protease inhibitors 
that occurs as a polymorphism in HIV-1 subtype C isolates. The 
T12S/T15V/L19I/I93L mutation pattern has been found in HIV-1 subtype C 
isolates from South Africa and north India, with the latter isolates also 
containing the additional L89M mutation (Arora et al., 2008). The mutations 
T69N and V75M in reverse transcriptase and L10F, K20I, L33I, and N88S in 
protease have been found more frequently in patients infected with 
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CRF01_AE than in patients with subtype B (Ariyoshi et al., 2003; Ataher et al., 
2012). 
4.5 HIV diversity and vaccine design 
The rapid evolution and extreme genetic diversity of HIV represent a 
formidable challenge to the development of a vaccine (Garber et al., 2004). 
The extreme genetic diversity of HIV imposes a formidable challenge in terms 
of choosing a vaccine strain including whether it would be based on an isolate 
derived from a particular subtype selected from a geographic region for which 
the vaccine is intended, constructing a consensus sequence, and using an 
ancestral sequence reconstructed on the basis of an evolutionary model 
(Gaschen et al., 2002). 
It has been established that serum and HIV-1 isolate neutralization serotypes 
do not generally correspond directly to the genetic subtypes, that is sera from 
patients infected with subtype A viruses does not preferentially neutralized 
subtype A viruses. Thus putative serum and isolate neutralization serotypes 
are not identical to and presently cannot be predicted by knowledge of the 
genetic subtypes alone. However, subtypes B and E form discrete 
neutralization serotypes when compared directly against each other. The 
envelope glycoproteins from subtypes B and E occupy opposite extremes of 
the antigenic diversity spectrum, which accounts for the virtual dependency of 
subtype to the outcome of neutralization assays that characterizes the two 
subtypes. Ultimately, that genetic subtypes do not directly correspond to 
neutralization serotypes stems from the fact that HIV-1 subtypes are defined 
on the basis of primary sequence, whereas virus neutralization is a much 
more complex process which depends on antibody interactions with epitopes 
that are influenced by the tertiary and quaternary structures of glycoprotein 
oligomers (Gaschen et al., 2002; Kostrikis et al., 1996; Moore et al., 1996; 
Moore et al., 2001). 
There is some evidence that viral genetic subtype may also be important as 
the breadth and potency of humoral responses is reported to be higher in 
subtype C and A than in subtype B infections (Overbaugh and Morris, 2012). 
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The MHC-restricted host immune response, which represents a continuous 
selective force on pathogens, may be influenced significantly by subtype-
dependent amino acid sequence variation (Kosakovsky Pond, et al 2009; 
Moore et al., 1996). It has been found that MHC class I epitopes containing 
even a single amino acid substitution could not be recognized by T cell 
receptors, precluding the possibility of using a single natural isolate for a 
vaccine protecting against either a different subtype or even many variants 
from the same subtype (Cao et al., 1997; Létourneau et al., 2007). Single 
amino acid changes may further undermine MHC class I restricted CTL 
responses by diminishing recognition of a given epitope by the host’s CD8+ T 
cells through either loss of epitope binding to MHC I molecules, or 
preservation of binding to MHC class I but alteration of protein processing 
such that immunogenic epitopes are no longer presented for recognition by a 
T-cell receptor (Cao et al., 1997; Garber et al., 2004). However, a subset of 
HLA A3 positive persons infected with HIV-1 non-B subtypes revealed 
frequent recognition of A3-restricted epitopes that has been well described in 
individuals infected with clade B virus, suggesting that CTL cross-subtype 
reactivity among persons infected with clade B and non-B viruses may take 
place, resulting in MHC class I restricted CTL recognition of immunogenic 
epitopes despite single or even double amino acid substitutions (Cao et al., 
1997). 
In addition, high rates of genomic recombination allow for mixing and 
matching of the most favoured mutations associated with escape from host 
humoral and cellular immune responses, and minimisation of viral fitness 
costs incurred by individual escape mutations. Both mutational and 
recombination mechanisms of HIV diversification rely on ongoing, active virus 
replication and generate extensive pools of mutant viruses from which host 
immune responses may select for resistant variants (Garber, D. A., et al.). 
5. Global distribution of HIV-1 subtypes 
The global distribution of the different HIV-1 subtypes and recombinants and 
shifts in that distribution probably arose from various causes including lineage 
founder effects, population growth and urbanization and improved transport 
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links and migration (Table 1.3.). The actual role of the biological properties of 
different subtypes and recombinants in their uneven distribution has yet to be 
determined (Hemelaar et al., 2011; Rambaut et al., 2004). 
The initial diversification of group M may have occurred within or near the 
DRC, where the highest diversity of group M strains has been observed and 
the earliest cases of HIV-1 infection (1959 and 1960) have been documented. 
More precisely, molecular epidemiological studies revealed that the epicenter 
of the HIV pandemic is situated in the area of Kinshasa, the capital city of the 
DRC, where the highest genetic diversity of HIV-1 M, in number of 
cocirculating subtypes, intrasubtype diversity, and recombinants, has been 
observed and about 5% of sequences reported from DRC are not clustering 
with any of the known HIV-1 variants. Interestingly, the geographic distribution 
of HIV-1M variants is also heterogeneous within the country, and between 6 
and 11 HIV-1 variants cocirculate in the different regions studied. The highest 
genetic diversity has been observed in Kinshasa and subtype A is the most 
prevalent variant in almost each region, except in the extreme south where 
subtype C largely predominates. Subtypes D, G, and H were found mostly in 
the northern and western parts of the country. In Kisangani, in the northeast, 
subtypes A and D are relatively well represented, as in countries bordering the 
DRC in the northeast (Djoko et al., 2011; Keele et al., 2006; Vidal et al., 2000; 
Worobey, 2008). 
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Table 1.3. The global prevalence and geographic location of the 11 most prevalent 
HIV-1 subtypes and circulating recomninant forms (Source: Hemelaar et al., 2011).  
Subtype/CRF Global Prevalence Geographic Location 
A 12% East and central Africa 
Eastern Europe 
Central Asia 
B 11% Amercas 
Western Europe 
Oceania 
Middle East and North Africa 
East Asia 
C 48% Southern Africa 
Ethiopia 
East Africa  
India 
Brazil 
D 2% Eastern Africa 
Central Africa  
West Africa 
F 1% Widely and evenly spread worldwide. 
G 5% West and central Africa 
H, J and K 1% Central, southern and West Africa 
CRF01_AE 5% South and south-east Asia 
CRF02_AG 8% West Africa 
Other CRFs 3% Widely and evenly spread worldwide 
URFs 4% Widely and evenly spread worldwide 
 
There has been an increase in the global proportion and absolute growth of 
the epidemics of subtypes A, F, G, H, CRF01_AE, CRF02_AG and other 
CRFs, while the epidemics caused by subtypes D, J, K, CRF03_AB and URFs 
have decreased in size, with the concomitant reduction in their proportion of 
the global total (Figure 1.7). However, the epidemics caused by subtypes B 
and C grew at a rate below the average, which reduced their proportion of the 
global epidemic even though subtype C was still responsible for the largest 
absolute increase in the number of infections (Hemelaar et al., 2011).  
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While some of the CRFs that are important in the global epidemic are found in 
central Africa and in particular in the DRC, for example CRF01_AE and 
CRF02_AG, other CRFs that have become important in the epidemic seem to 
have arisen due to recombination events involving subtypes that are co-
circulating in a particular geographic region, for example CRF31_BC and 
CRF07_BC in Brazil and China, respectively (Hemelaar et al., 2011).  
 
Figure 1.9. Global distribution of HIV-1 subtypes and recombinants. In the main 
figure, pie charts representing the distribution of HIV-1 subtypes and recombinants 
from 2004 to 2007 in each region are superimposed on the regions. The relative 
surface areas of the pie charts correspond to the relative numbers of people living 
with HIV in the regions. The colours representing the different HIV-1 subtypes and 
recombinants are indicated in the legend on the left-hand side of the figure. The HIV-
1 subtype distributions found around the world and within Central African countries 
are shown in the insets of the main figure, as indicated (Source: Hemelaar et al, 
2011). 
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6. Molecular epidemiology of HIV in South Africa 
The explosive HIV-1 epidemic in southern Africa is characterized by very 
limited subtype diversity. HIV-1 subtype C is the most common subtype, 
accounting for the majority of HIV infections in southern Africa, while other 
subtypes, particularly subtypes B and D, have been identified (Abreu et al., 
2008; Becker et al., 1995; Bredell et al., 2002; Engelbrecht et al., 1995; 
Hemelaar et al., 2011; Jacobs et al., 2009; Lihana et al., 2012; Novitsky et al., 
1999; Van Harmelen et al., 1999; Williamson et al., 1995). In South Africa 
HIV-1 subtypes and recombinants such as F1, G, AC, AD, AG, CG, and CH 
have also been identified (Fish et al., 2010 Jacobs et al., 2009; Wilkinson and 
Engelbrect, 2009). Molecular epidemiological investigations in South Africa 
have, with the notable exceptions of the Free State, Limpopo and 
Mpumalanga, largely focused on provinces with major metropolitan centers 
such as Guateng, the Western Cape and KwaZulu Natal. Hardly any 
molecular epidemiological studies have been undertaken in the Eastern Cape, 
North West and Northern Cape provinces (Table 1.4.). HIV-1 subtype C is 
primarily transmitted heterosexually and affects mostly black Africans, and 
subtype B is associated with homosexual transmission amongst white males, 
which may account for the hitherto lack of instances of recombination between 
the two subtypes in South Africa. But sex between men could be an important 
factor in the HIV/AIDS epidemic in southern Africa, replicating the pattern 
prevailing elsewhere in the world in which men who engage in sex with other 
men often tend to be involved in relationships with women (Van Harmelen, et 
al., 1997; Van Griensven, 2007). 
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Table 1.4. The distribution of HIV-1 subtypes and CRFs by province in South Africa.  
Province Subtype/CRF Genomic 
region 
Year  Reference 
Eastern Cape — — — — 
Free Sate C 
B, C 
pol 
env 
2009 
1999 
Huang, et al., 2009 
Van Harmelen, et al., 1999 
Gauteng C, AC, CG 
C 
A, D, G, AG 
C 
C 
C, B 
C, B 
C 
Integrase 
Near full length 
Full length 
gag and env  
Full length 
env V3 
env 
env V3-V5 
2010 
2001 
2003 
2002 
2002 
1999 
1999 
1998 
Fish et al., 2010 
Hunt et al., 2001 
Papathanasopoulos et al., 2003 
Bredell et al., 2002 
Papathanasopoulos et al., 2003 
Engelbrecht et al., 1999 
Van Harmelen et al., 1999 
Bredell et al 1998 
Kwa-Zulu Natal C 
C 
A, D, G, AG, AC 
 
B, C 
pol 
pol and env 
gag and env  
env V3 
env 
2008 
2003 
2002 
1999 
1999 
Marconi et al., 2008 
Gordon et al., 2003 
Bredell et al., 2002 
Engelbrecht et al., 1999 
Van Harmelen et al., 1999 
Limpopo C 
C 
C 
gag, pol and env 
pol 
env and gag 
2012 
2006 
2005 
Iweriebor et al., 2012 
Bessong et al., 2006 
Bessong et al., 2005 
Mpumalanga C, B env V3 1999 Engelbrecht et al., 1999 
Northern Cape — — — — 
North West — — — — 
Western Cape A1, B, AC, AD 
B, C 
A, B, C, F1, G, CH, U 
C, B 
B, C, G, AG 
D 
C, D 
B, C 
B, C 
C, B 
A, C 
B, C, D 
A, C 
B, C, D 
Near full length 
vpr 
env V3 
vif 
pol 
Near full length 
env and gag 
env 
Full length 
env V3 
env 
env and gag 
env 
gag 
2009 
2009 
2009 
2008 
2008 
2007 
2006 
2002 
2002 
199 
1999 
1995 
1995 
1995 
Wilkinson & Engelbrecht, 2009 
Romani et al., 2009 
Jacobs et al., 2009 
Jacobs et al., 2008a 
Jacob et al., 2008b 
Jacobs et al., 2007 
Jacobs et al., 2006 
Treurnicht et al., 2002. 
Van Harmelen et al., 2001 
Engelbrecht  et al., 1999 
Van Harmelen et al., 1999 
Becker  et al., 1995 
Engelbrecht et al., 1995 
Williamson et al., 1995 
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7. Methods for detecting HIV-1 diversity. 
There are several laboratory methods that are used for the detection of HIV-1 
diversity. The methods encompass nucleic acid testing and serological 
methods and include sequencing, PCR-based methods such as heteroduplex 
mobility assays and serological methods (Table 1.5.). The sheer accumulation 
of HIV-1 nucleotide sequences in databases, and their preponderant use in 
studies on HIV-1 diversity, suggests that sequencing represents the best 
method for HIV-1 diversity. Serological assays are more effective in screeing 
populations of limited subtype diversity, for example in situations in which only 
one subtype predominates. In epidemics that are characterized by the co-
circulation of multiple subtypes serological assays may lead to subtype 
misclassification because of cross reactivity. Unlike serological assays, PCR-
based methods for the detection HIV-1 diversity such as heteroduplex mobility 
assays have been more effective in detecting HIV variants from in countries 
where extreme subtype diversity occurs. The use of partial sequences from 
different regions of the HIV genome such as gag and env has allowed 
prevalence of recombinants to be determined (McCutchan, 1999; Tatt et al., 
2001). 
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Table 1.5. HIV-1 subype classification schemes (Source: Tatt et al., 2001). 
Method Technique Advantages  Disadvantages  
Sequencing Sequencing all or part of 
the genome 
Accurate 
Recombinant identification 
indicates transmission 
events  
Prediction of antiviral 
resistance 
Labour intensive and time 
consuming 
Expensive 
PCR-based Heteroduplex mobility 
assay 
Accurate 
Inexpensive 
Applicable in areas of 
multiple HIV-1 subtypes 
Reference sequences and 
primers may require 
updating 
May not detect 
diverse/novel subtypes or 
CRFs 
Restriction fragment 
length polymorphism 
Inexpensive 
High Specimen throughput 
Applicable only in areas 
limited subtype diversity 
May not detect CRFs 
Oligonucleotide probe 
hybridization 
Inexpensive 
High throughput 
Subtype diversity affects 
probe hybridization 
Lacks specificity in areas of 
multiple subtype  
Combinatorial DNA 
melting assay 
Discrimination between 
multiple subtypes 
Reference sequences can 
be tailored to a specific 
population 
Reduced performance in 
areas of multiple subtype 
Reference sequences 
require continual updating 
NASBA-
based 
Molecular beacons and 
oligonucleotide probes 
Real-time results Requires probes for all 
subtypes 
Serological 
assays 
Peptide-based enzyme 
immunosorbent assays 
Inexpensive 
High specimen throughput 
Relatively simple to perform 
Cross-reactivity in areas of 
multiple subtypes 
Applicable only in areas of 
limited subtype diversity 
Does not detect CRFs 
8. Transmitted drug resistance 
While combination antiretroviral therapy can suppress HIV replication to 
undetectable levels to produce with concomitant significant clinical outcomes, 
suboptimal suppression HIV replication can result in the emergence of drug 
resistant virus strains. Expert panels from the United Sates of America 
Department of Health and Human Services, the International Aids Society - 
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United States, and the EuroGuidlines Group recommend the use of drug 
resistance testing for resistance mutations (DRMs) associated with reduced 
viral response to antiretroviral treatment in the management of HIV infected 
patients. HIV isolates that have acquired mutations conferring reduced 
susceptibility to antiretroviral drugs can be can be transmitted, potentially 
limiting options for first line therapy in untreated individuals. Surveillance of 
transmitted HIV drug resistance (HIVDR) mutations therefore has profound 
public health implications (Gifford et al., 2009; Shafer et al., 2008). 
To ensure uniformity and consistency between the disparate HIV drug 
resistance surveillance programmes underway in different countries and 
regions a standard list of mutations to characterize the epidemiology of 
transmitted drug resistance has been developed. A standard list of mutations 
affords comparison of the prevalence of transmitted resistance from different 
times and regions and allows meta-analyses of surveillance data collected by 
different groups at different times. The SDRM list should be recognized as 
causing or contributing to drug resistance – defined as being present on three 
or more of five expert lists of drug resistance mutations, the mutations should 
be non-polymorphic and should not occur at highly polymorphic positions, the 
mutation list had to be applicable to the eight most common HIV-1 subtypes, 
and the list should be parsimonious, excluding mutations resulting 
exceedingly rarely from drug pressure. While phylogenetically-linked stably 
transmitted resistant variants, for example the A62V NRTI mutation found in 
HIV-1 subtype A isolates, may also adversely impact treatment outcomes and 
exacerbate public health challenges arising from transmitted drug resistance, 
they may also bias SDRMs lists (Bennett et al., 2009; Shafer et al., 2008). 
9. An overview of phylogenetic analysis 
A phylogenetic tree is a diagrammatic representation of the evolutionary 
relationship between different nucleotide or amino acid sequences. A 
phylogenetic tree is composed of branches and nodes (Figure 1.10.). 
Branches, which are also called edges, connect nodes; a node is the point at 
which two, or more, branches diverge. Branches and nodes can be internal or 
external. External nodes are also designated terminal nodes. An internal node 
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corresponds to the hypothetical last common ancestor (LCA) of everything 
arising from it. External nodes represent entities that are being compared, and 
they are called operational taxonomic units (OTUs), and internal nodes 
represent ancestral units, which are hypothetical, the objective is to group 
extant units. Terminal nodes correspond to the sequences, or operational 
taxonomic units or OTUs, from which the tree was derived (Baldauf, 2003). 
The branching pattern – that is, the order of the nodes – is called the topology 
of the tree (Vandamme, 2003). 
 
 
Figure 1.10. Example of a phylogeny with included terminology. Sister taxa are two 
taxa derived from a common ancestral node, they are each other’s closest relatives; 
a monophyletic group includes an ancestor with all its descendents; a polytomy is an 
internal node with more than 2 immediate descendants, representing either 
simultaneous divergence or an unresolved node (Source: Egan and Crandall, 
Unpublished).  
Trees can be rooted or unrooted (Figure 1.11.). Rooted trees have a time 
direction whereas unrooted trees do not. Rooted trees have a root that 
denotes common ancestry of all OTUs under study, and unrooted trees only 
specify the evolutionary relationship among taxa and not their evolutionary 
paths. The branching pattern of a tree is the tree’s topology, and branch 
length reflects the amount of difference that has occurred along a branch 
(Baldauf, 2003). Most phylogenetic methods produce unrooted trees. This is 
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because they detect differences between sequences, but have no means to 
orient residue changes relatively to time.  
 
 
Figure 1.11. Examples of a rooted (A) and unrooted (B) trees (Source: Vandamme, 
2003).  
 
10. HIV-1 molecular phylogenetic methods  
10.1 Assembling a DNA sequence dataset 
Phylogenetic analysis to infer evolutionary relationships between organisms or 
genes involves the use of homologous sequence data, which can be obtained 
from the laboratory bench using molecular biology techniques or retrieved 
from sequence databases such as the LANL HIV Sequence Database. An 
out-group sequence is also included to root the tree, indicating which nodes in 
the tree are the oldest, and providing indications about ancestral sequence 
states or ancestral descendent relationships (San Mauro and Agorreta, 2010). 
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10.2 Multiple sequence alignment 
Phylogenetic reconstruction methods require a set of aligned sequences. The 
alignment is the statement of homology, that is, shared ancestry from which 
historical inferences are made. Sequences may diverge from each other, 
indels may accumulate, and gaps need to be inserted into sequences to 
increase their similarity. The alignment is an arrangement of the sequences 
into a matrix so that the character states at each given position, column of the 
matrix, are related to each other by descent from a common ancestral 
residue, that is there is positional homology. There are two fundamental ways 
of treating data; as distances or as discrete characters. Distance methods first 
convert aligned sequences into a pairwise distance matrix, which is then used 
in a matrix to build a tree. Discrete methods consider each nucleotide site, or 
some function of each site, directly (Egan and Crandall, Unpublished; San 
Mauro and Agorreta, 2010). 
10.3 Nucleotide substitution models 
The most widely and generally useful nucleotide substitution models are those 
from the General Time-Reversible (GTR) family. Within this family we find all 
the standard nucleotide substitution models (JC69, K80 or K2P, F81, HKY85, 
TN93, GTR). The Jukes-Cantor model (JC69) is the simplest, assuming that 
equilibrium nucleotide frequencies are equal and that any nucleotide can 
change to any other with equal probability (Figure 1.12.) (Liò and Goldman, 
1998) The Kimura 2-parameter model (K2P) allows for differences in transition 
and transversion rates while keeping equal base frequencies. The Felsenstein 
1981 model (F81) allows some bases to be more common than others while 
keeping substitution probabilities equal. F81 assumes that base frequencies 
are similar across sequences. Combining F81 and K2P gives the Hasegawa, 
Kishino, and Yano model (HKY85) which allows variation in base frequencies 
and transition/transversion bias. The general time reversible model (GTR) 
builds on HKY85 by permitting each of the six substitution pairs to have 
different rates. GTR contains the other models nested within it (Liò and 
Goldman, 1998; Leitner et al., 1997) 
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10.4 Major methods for estimating phylogenetic trees 
10.4.1 Distance methods: Neighbor-joining method 
The neighbor-joining method is an algorithm that uses genetic distances to 
construct a phylogeny by the sequential addition of taxa (Rambaut et al., 
2004). These are pairwise distance methods based on the assumption that 
dissimilarity between two sequences is directly related to their phylogenetic 
relationship. Such dissimilarity arises from the number of changes that have 
occurred along the branches, i.e. the evolutionary distance. In the neighbour-
joining method, the DNA or amino acid sequences are first converted into a 
distance matrix that is then used to reconstruct a phylogenetic tree (San 
Mauro, and Agorreta, 2010). 
 
 
Figure 1.12. The Jukes-Cantor model (JC69) and Kimura 2-parameter model 
(K2P). α =transition rate; β = transversion rate (Source: Egan and Crandall, 
unpublished). 
These are pairwise distance methods based on the assumption that 
dissimilarity between two sequences is directly related to their phylogenetic 
relationship. Such dissimilarity arises from the number of changes that have 
occurred along the branches, i.e. the evolutionary distance. Distance methods 
comprise both clustering methods such as Neighbour-Joining, and optimality 
methods such as minimum evolution. Distance methods comprise both 
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clustering methods such as neighbour-joining, and optimality methods such as 
minimum evolution. Clustering methods were originally developed to detect 
similarities rather than to estimate evolutionary relationships. In minimum 
evolution, the optimality criterion is the sum of branch lengths optimized 
according to the least-squares criterion above (the minimum evolution score) 
(San Mauro and Agorreta, 2010). 
10.4.2 Maximum likelihood methods  
Maximum likelihood methods select the tree that has the highest probability of 
explaining the sequence data, under a specific model of substitution, that is, 
changes in the nucleotide or amino-acid sequence (Rambaut, Posada, 
Crandall, Holmes, 2004). In the context of molecular systematics, the 
likelihood of a phylogenetic tree is the probability of observing the data, or the 
set of sequences being analyzed, given the tree and the model of evolution. 
The likelihood of a site is the probability of the observed states at that site 
given all the possible combinations of states at the internal nodes of the tree, 
that is, ancestral states. The likelihood of a tree is the product of the 
likelihoods for each site of the alignment. The great advantage of maximum 
likelihood is that it allows the inference of phylogenetic trees using complex 
models of sequence evolution, including the ability to estimate model 
parameters, thus allowing simultaneous inference of patterns and processes 
of molecular evolution, and provides a powerful statistical framework for 
hypotheses testing (San Mauro and Agorreta, 2010). 
10.4.3 Bayesian inference 
Bayesian inference focuses on the quantity known as the posterior probability, 
defined as the probability of some hypothesis conditional on the observed 
data. The posterior probability is proportional to the product of the likelihood of 
the data, given that the hypothesis is correct and the prior probability of the 
hypothesis before any data have been collected. In Bayesian phylogenetics, 
parameters such as the tree topology, branch lengths, and substitution 
parameters, are modeled as probability distributions. Using Bayes’s theorem, 
the posterior probability of any of one of these parameters may be expressed 
as the marginal distribution of those remaining. Solving analytically for the 
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posterior probability requires the integration of the likelihood function over all 
possible values of the remaining parameters, which is effectively intractable 
for even moderately complex problems. Modern Bayesian methods use 
Markov chain Monte Carlo methods to approximate this integration by 
simulating draws from the joint posterior distribution of all model parameters. 
Posterior probabilities for the parameters of interest are calculated using the 
Markov chain samples. For example, the posterior probability of a tree or 
bipartition in a tree is determined simply by examining the proportion of all of 
the Markov-chain samples that contain the topological bipartition of interest 
(Alfaro et al., 2003). 
10.5 Confidence Assessment 
10.5.1 The Bootstrap  
The nonparametric bootstrap procedure is commonly used for estimating 
nodal support under traditional methods of phylogenetic inference. The 
bootstrap procedure re-samples the original data set to create a new data set 
by choosing columns of data from the original data matrix at random with 
replacement until a new data matrix is created that has the same sequence 
length as the original. Then a tree is estimated from this re-sampled data set. 
This procedure is repeated multiple times (typically 100 for ML and 1000 or 
more for MP, ME, and NJ) to achieve reasonable precision (Felsenstein, 
1985). 
10.5.2 Posterior Probability 
Posterior probability has a straightforward interpretation as the probability that 
a particular monophyletic group is correct. 
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11. Aims and objectives 
HIV diversity may have implications for diagnosis, pathogenesis, transmission, 
clinical management and vaccine development. Phylogenetic analysis of HIV 
sequence diversity has allowed vital insights into the origin, evolution and 
spread of HIV, which suggests it is imperative to maintain HIV molecular 
epidemiology surveillance. Molecular epidemiological investigations in South 
Africa have, with the notable exceptions of the Free State and Limpopo, 
largely focused on provinces with major metropolitan centers such as 
Guateng, the Western Cape and KwaZulu Natal. Hardly any molecular 
epidemiological studies have been undertaken in the Eastern Cape, 
Mpumalanga, North West and Northern Cape provinces. 
11. 1 Aim 
The aim of the project was to investigate HIV-1 subtype diversity using 
different samples obtained from a cohort in Bushbuckridge, Mpumalanga 
between February and July 2009. 
11.2 Objectives 
To achieve the aim of the study, the following objectives were set: 
1. Viral RNA isolation 
2. Amplification of partial gag, pol (PR/RT and IN) and env gp41 regions 
3. Sequencing of amplified fragments  
4. Molecular characterization of sequenced fragments using online tools 
5. Phylogenetic analysis using MEGA software. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Patient cohort  
Samples were obtained from Bushbuckridge in Mpumalanga and kindly 
provided for this study by Dr E Vardas. The Prevalence, Incidence and 
Molecular Epidemiology (PIME) study has been granted ethical approval by 
the Provincial Research and Ethics Committee, Department of Health and 
Social Services, Mpumalanga Provincial Government. The Human Research 
Ethics Committee (HREC) at the Faculty of Medicine and Health Sciences of 
Stellenbosch University also approved the study. 
2.2 Reagents and equipment used 
The reagents and equipment used are listed in the Table 2.1 and Table 2.2 
respectively. Also provided are lists of the software used and databases 
(Tables 2.3 and Table 2.4). A diagram of the the methods used are 
summarized in Figure 2.1. 
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Table 2.1. Reagents used in the experiments. 
Product Company 
QIAamp MinElute Virus Spin Kit Qiagen, Dusseldorf, Germany 
Access RT-PCR Promega Madison, WI, USA 
GoTaq® Flexi DNA Polymerase Promega Madison, WI, USA 
dNTPs Promega Madison, WI, USA 
Nuclease-free Water Promega Madison, WI, USA 
Agarose Whitehead Scientific 
Ethidium Bromide Promega Madison, WI, USA 
6x Blue Orange Loading Dye Promega Madison, WI, USA 
Wizard SV Gel and PCR Clean-up Kit Promega Madison, WI, USA 
1 kb DNA Ladder Promega Madison, WI, USA 
ExoSAP-IT® USB Cleveland, Ohio 
QIAquick PCR Purification Kit QIAGEN, Dusseldorf, Germany 
Big Dye Terminator v 3.1 Cycle Sequencing Kit Applied BioSystems, CA, USA 
%x Sequencing Buffer Applied BioSystems, CA, USA 
Big Dye X Terminator Purification Kit Applied BioSystems, CA, USA 
 
Table 2.2. Equipment used in the experiments. 
Equipment Supplier Location 
Eppendorf Centrifuge 5417C Eppendorf, Hamburg, Germany 
Eppendorf Centrifuge 5415D  Eppendorf, Hamburg, Germany 
GeneAmp® 9700 PCR Thermocycler Applied BioSystems, California, USA 
NanoDrop ND 1000 Spectrophotometer NanoDrop Technologies Inc., Delaware, USA 
Vortex Mixer VM 300 Gemmy Industrial Corp, Taipei, Taiwan 
QIAcube QIAGEN, Hilden, Germany 
UVItec Gel Documentation System UVItec Limited, Cambridge 
United Kingdom 
Hoefer EPS 2 A 200, Power Pack Pharmacia Biotechnologies, CA, USA 
ABI 3130xl Automated Sequencer Applied BioSystems, CA, USA 
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Table 2.3. Software packages used in the analysis of sequences. 
Software package Reference / or Licensed Company 
Sequencher 4.8 Gene Codes Corporation, Ann Arbor, MI, USA 
Clustal X Thompson et al., 1997 
BioEdit v5.0.9 Hall, 2003. Ibis Biosciences 
MEGA v5.0 Tamura et al., 2011 
jpHMM Spang et al., 2002 
REGA v 3.0 HIV subtyping tool De Oliveira et al., 2005 
 
 
Table 2.4. Databases used in the analysis of sequences. 
Databases Web Address 
Los Alamos National Laboratory HIV Sequence Database http://www.hiv.lanl.gov 
Stanford HIV RT and Protease Sequence Database http://hivdb.stanford.edu 
BioAfrica  http://www.bioafrica.net 
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Figure 2.1. A flow diagram of the methods used in the study.  
2.3 Viral RNA extraction. 
HIV RNA was extracted from patient plasma samples using a QIAamp 
MinElute Virus Spin Kit in a QIAcube automated extractor (QIAGEN, 
Dusseldorf, Germany) at the Stellenbosch University Division of Medical 
Virology, according to the manufacturer’s instructions. 
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2.4 PCR of different HIV-1 gene fragment 
The reverse transcription PCR of the partial HIV-1 gag p24, pol PR p10, RT 
p66/51, IN p32 and env gp41 gene fragments was performed using the 
Access RT-PCR System (Promega, Madison, Wisconsin, United States of 
America). The Access RT-PCR System is a one-tube, two-enzyme system 
that uses AMV Reverse Transcriptase (AMV RT) from Avian Myeloblastosis 
Virus for first strand cDNA synthesis and the thermostable Tfl DNA 
polymerase from Thermus flavus for second strand DNA synthesis and DNA 
amplification. The RT-PCR reaction was carried out in an AMV/Tfl 5X 
Reaction Buffer, and the nested polymerase chain reaction (PCR) of the 
partial HIV-1 gag p24 pol p10, p66/51, p32 and env gp41 gene fragments was 
undertaken utilizing the Promega GoTaq Flexi DNA polymerase derived from 
Thermus aquaticus. The GoTaq Flexi DNA polymerase, which exhibits 5′→3′ 
exonuclease activity, is a thermostable enzyme that catalyzes the 
polymerazition of nucleotides into duplex DNA in a 5′→3′ direction in the 
presence of magnesium. The nested PCR reaction was carried in a 5X GoTaq 
Flexi Buffer. The oligonucleotide primers used in the amplification of the 
partial HIV-1 gag p24, pol p10, p66/51, p32 and env gp41 gene fragments, 
their locations with respect to the HXB2 reference strain, and their annealing 
temperatures, are in Table 2.5.  
2.4.1 Partial gag p24 gene fragment  
Five microliters of the RNA extract was used to generate a cDNA template, 
which was amplified in a 50 μl reaction mixture comprising 2mM MgSO4, 
40pmol each of the first round PCR forward and reverse primers (Swanson, 
Devare, Hackett, 2003, in Table 2.5), 0.2 mM dNTPs and the final 
concentration of 0.1U each of the AMV Reverse Transcriptase and the Tfl 
DNA Polymerase. The reactions were carried out in a GeneAmp 9700 PCR 
System (Applied Biosystems) thermocycler according to the following cycling 
parameters indicated in Table 2.6.  
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One microliter of the first round DNA was amplified in a nested 50 μl reaction 
mixture comprising 1.5mM MgCl2, 40pmol each of the nested PCR forward 
and reverse primers, as well as 0.2mM dNTPs and the final concentration of 
1U of the GoTaq DNA Polymerase according to cycling parameters described 
in Table 2.6.  
Table 2.5. Primers used in the amplification of the partial HIV-1 gene products. 
 Primer Oligonucleotide sequence F/R HXB2  
Location 
TM 
(°C) 
gag p24: Capsid Sequences 
cDNA 
and 
first 
round 
PCR 
p24-7 CCCTGRCATGCTGTCATCA R 1826←1844 55.2 
p24-1 AGYCAAAATTAYCCYATAGT F 1174→1193 56.3 
Nested 
PCR 
p24-2 AGRACYTTRAAYGCATGGGT F 1237→1256 50.0 
p24-6  TGTGWAGCTTGYTCRGCTC R 1703←1721 50.0 
pol p10 and p66/51: Protease and Reverse Transcriptase Sequences 
cDNA 
and 
first 
round 
PCR 
PR-5′ prot -1 TAATTTTTTAGGGAAGATCTGGCCTTCC F 2082→2109 57.0 
RT-MJ4 CTGTTAGTGCTTTGGTTCCTCT R 3399←3420 55.0 
Nested 
PCR 
PR-5′ prot-2 TCAGAGCAGACCAGAGCCAACAGCCCCA F 2136→2163 68.0 
RT-NE135 CCTACTAACTTCTGTATGTCATTGACAGTCCAGCT R 3300←3334 62.0 
pol p32 Integrase Sequences 
cDNA 
and 
first 
round 
PCR 
poli8 TAGTGGGATGTGTACTTCTGAAC R 5195←5217 55.0 
poli5 CACACAAAGGRATTGGAGGAAATG F 4162→4185 57.0 
Nested 
PCR 
poli7 AACAAGTAGATAAATTAGTCAGT F 4186→4208 49.0 
poli6 ATACATATGRTGTTTTACTAARCT R 5107←5130 48.0 
env gp41 Transmembrane Glycoprotein Sequences 
cDNA 
and 
first 
round 
PCR 
JH38 GGTGARTATCCCTKCCTAAC R 8346←8365 52.9 
JH41 CAGCAGGWAGCACKATGGG F 7816→7835 57.4 
Nested 
PCR 
 
env27_Fc CTGGYATAGTGCARCARCA F 7861→7879 54.9 
Menv19_Rgg AARCCTCCTACTATCATTATRA R 8278←8299 49.4 
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Table 2.6. Cycling conditions for the PreNested and Nested gag p24 PCR assays.  
Cycling conditions of the PreNested gag p24 PCR assay 
Step Temperature Duration Cycles 
Reverse transcription 48°C 45 min x1 
Initial Denature Step 94°C 2 min x1 
Denature 94°C 20 sec  
x40 Anneal 45°C 30 sec 
Extend 68°C 90 sec 
Final Extension 68°C 10 min x1 
Cycling conditions for the Nested gag p24 PCR assay 
Step Temperature Duration Cycles 
Initial Fenature Step 94°C 2 min x1 
Denature 94°C 20 sec  
x40 Anneal 50°C 30 sec 
Extend 68°C 60 sec 
Final Extension 68°C 10 min x1 
sec – seconds, min – minutes, °C – degrees Celsius, gag – Group-specific 
antigen gene. 
2.4.2 Partial pol p10 and p66/51 gene fragment. 
The primers used were described by Plantier and collaborators, 2005. The 
partial pol reverse transcription reaction mixture included 1mM MgSO4, and 
0.2mM of dNTPS and the final concentration of 1.1U each of the AMV 
Reverse Transcriptase and the Tfl DNA Polymerase and 40pmol each of the 
primers.  
One microliter of the first round DNA was amplified in a nested 50 μl reaction 
mixture and included 0.2mM dNTPs, a final concentration of 1.25 U of the 
GoTaq DNA Polymerase and 40pmol each of the primers. The cycling 
conditions for the pol PCR are listed in Table 2.7. 
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Table 2.7. Cycling conditions for the PreNested and Nested reverse transcriptase-
pol PCR assays. 
Cycling conditions of the PreNested pol PCR assay 
Step Temperature Duration Cycles 
Reverse transcription 48°C 45 min x1 
Initial Denature Step 94°C 2 min x1 
Denature 94°C 20 sec  
x40 Anneal 55°C 30 sec 
Extend 68°C 90 sec 
Final Extension 68°C 10 min x1 
Cycling conditions for the Nested gag p24 PCR assay 
Step Temperature Duration Cycles 
Initial denature Step 94°C 2 min x1 
Denature 94°C 20 sec  
x40 Anneal 55°C 30sec 
Extend 68°C 60 sec 
Final Extension 68°C 10 min x1 
sec – seconds, min – minutes, °C – degrees Celsius, pol -Polymerase 
2.4.3 Partial pol IN p32 gene fragment. 
Five microliters of the RNA extract was used to generate a cDNA template, 
which was amplified, in a 50 μl reaction mixture comprising 2mM MgSO4, 
40pmol of each of the cDNA and first round PCR forward and reverse primers 
(Swanson, Devare, Hackett, 2003), and 0.2mM dNTPs and the final 
concentration of 0.1U each of the AMV Reverse Transcriptase and the Tfl 
DNA Polymerase. The reactions were carried out in a GeneAmp 9700 PCR 
System (Applied Biosystems) thermocycler according to cycling parameters 
listed in Table 2.8. 
Three microliters of the template DNA was amplified in a 50 μl reaction 
mixture comprising 1.5mM MgCl2, 40pmol each of the nested PCR forward 
and reverse primers, as well as 0.2mM dNTPs and the final concentration of 
0.05U of the GoTaq DNA Polymerase. The reactions were carried out in a 
GeneAmp 9700 PCR System (Applied Biosystems) thermocycler according to 
cycling parameters listed in Table 2.8. 
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Table 2.8. Cycling conditions for the PreNested and Nested reverse transcriptase IN 
PCR assays. 
Cycling conditions of the PreNested pol p32 PCR assay 
Step Temperature Duration Cycles 
Reverse transcription 48°C 45 min x1 
Initial Denature Step 94°C 2 min x1 
Denature 94°C 20 sec  
x40 Anneal 50°C 30 sec 
Extend 68°C 90 sec 
Final Extension 68°C 10 min x1 
Cycling conditions for the Nested pol p32 PCR assay 
Step Temperature Duration Cycles 
Initial Fenature Step 94°C 2 min x1 
Denature 94°C 20 sec  
x40 Anneal 53°C 30 sec 
Extend 68°C 60 sec 
Final Extension 68°C 10 min x1 
sec – seconds, min – minutes, °C – degrees Celsius, pol – Polymerase 
IN – integrase. 
2.4.4 PCR amplification of the partial env gp41 
        gene fragment 
Five microliters of the RNA extract was used to generate a cDNA template, 
which was amplified, in a 50 μl reaction mixture comprising 1.5mM MgSO4, 
40pmol of each of the cDNA and first round PCR forward and reverse primers 
(Ellenberger, et al., 1999; Swanson, Devare, Hackett, 2003), and final 
concentration of 0.2mM dNTPs and the final concentration of 0.1U each of the 
AMV Reverse Transcriptase and the Tfl DNA Polymerase. The reactions were 
carried out in a GeneAmp 9700 PCR System (Applied Biosystems) 
thermocycler according to cycling parameters listed in Table 2.9. 
One microliter of the template DNA was amplified in a 50 μl reaction mixture 
comprising 1.5mM MgCl2, 40pmol each of the nested PCR forward and 
reverse primers, as well as final concentration of 0.2mM dNTPs and the final 
concentration of 1U of the GoTaq DNA Polymerase. The reactions were 
carried out in a GeneAmp 9700 PCR System (Applied Biosystems) 
thermocycler according to cycling parameters listed in Table 2.9. 
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Table 2.9. Cycling conditions for the PreNested and Nested env gp41 PCR assays. 
Cycling conditions of the PreNested gp41 PCR assay 
Step Temperature Duration Cycles 
Reverse transcription 48°C 45 min x1 
Initial Denature Step 94°C 2 min x1 
Denature 94°C 20 sec  
x40 Anneal 58°C 30 sec 
Extend 68°C 90 sec 
Final Extension 68°C 7 min x1 
Cycling conditions for the Nested gp21 PCR assay 
Step Temperature Duration Cycles 
Initial Fenature Step 94°C 2 min x1 
Denature 94°C 20 sec  
x40 Anneal 44°C 30 sec 
Extend 68°C 60 sec 
Final Extension 68°C 10 min x1 
sec – seconds, min – minutes, °C – degrees Celsius, env - envelope 
2.5 Gel electrophoresis of PCR products  
The analysis of the nested amplification of the partial HIV-1 gag p24, pol PR 
p10, RT p66/51, IN p32 and env gp41 gene fragments was performed using 
agarose gel electrophoresis. The voltage applied on the agarose gel 
generates an electric field, and DNA molecules in the wells in the gel exposed 
to this electric field migrate toward the anode due to the negatively charged 
phosphates along the DNA backbone. The size of the DNA determines the 
rate at which it passes through the gel, which allows an effective separation of 
DNA fragment-length mixtures by electrophoresis. Molecules of linear, duplex 
DNA (form III) travel through gel matrices at a rate that is inversely 
proportional to the log10 of their molecular weight. The molecular weight of a 
fragment of interest can therefore be determined by comparing its mobility to 
the mobility of DNA standards of known molecular weight. Eight microliters of 
nested PCR product was run in 0.8% agarose gels at 50V for more or less 45 
minutes. Five microliters ethidium bromide was added to the agarose gel 
during preparation to facilitate visualization of DNA fragments, and the 
Promega 1kb DNA Ladder Marker was used as a molecular weight marker. 
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After the run the DNA bands were visualised on the UV transilluminator and 
photographed with the UVITEC gel documentation system. 
2.6 Clean-up of PCR products. 
The ExoSAP-IT is a method for the clean-up of PCR products that is based on 
Exonuclease I and Shrimp Alkaline Phosphatase and that eliminates 
unincorporated primers and dNTPs to ensure they do not interfere with 
downstream applications such as sequencing. The ExoSAP-IT cleanup 
reagent is added directly to the PCR product to degrade primers and 
dephosphorylate dNTPs that were not consumed in the reaction. The 
ExoSAP-IT reagent is active in commonly used PCR buffers, which precludes 
a change in buffers. The clean up is carried out for 15 minutes at 37°C, which 
is followed by a 15-minute incubation period at 80°C to completely inactivate 
both enzymes.  
2.7 Sequencing of different gene fragments. 
The cycle sequencing reaction of the partial HIV-1 gag p24, pol PR p10, RT 
p66/51, IN p32 and env gp41 gene fragments was carried out with the Big 
Dye® Terminator v 3.1 Cycle Sequencing Kit (Applied BioSystems). Twenty 
five nanograms of purified PCR product was sequenced in a 10 μl reaction 
mixture comprising 5 pmol of sequencing primer, 1.3 μl of Big Dye terminator 
enzyme mix (Applied Biosystems), and 2.7 μl of Half Dye (Bioline). Data on 
the primers used in the cycle sequencing reaction appear in Table 2.10 
(Ellenberger, et al., 1999; Lindström and Albert 2003; Plantier, et al., 2005; 
Swanson, Devare, Hackett, 2003). The reactions were carried out in a 
GeneAmp 9700 PCR System (Applied Biosystems) thermocycler according to 
the following cycling parameters: 25 cycles comprising 96°C for 10 seconds 
for denaturation, 50°C for 5 seconds for primer annealing, and 60°C for 4 
minutes for extension. Extension product purification, as well as the capillary 
electrophoresis and autoanalysis of the extension product using the ABI 
3130xl Genetic Analyzer, the Data Collection software and Sequencing 
Analysis Software, were carried out at the Central Analytical Facility of the 
Stellenbosch University. Upon completion of the capillary electrophoresis and 
autoanalysis, the Central Analytical Facility sent the sample files to the 
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Division of Medical Virology where the Sequencher 4.7 (Gene Codes 
Corporation, Ann Arbor., Michigan, USA) was used to assemble the trace data 
into contiguous fragments, which were then verified, edited and saved as a 
text file (.txt) for subsequent analysis.  
Table 2.10. Primers used in the sequencing of HIV-1 gene fragments. 
Primer Oligonucleotide sequence Base 
# 
F/R HXB2  
Location 
TM (°C) 
gag p24: Capsid Sequences 
p24-2 AGRACYTTRAAYGCATGGGT 20 F 1237→1256 50 
p24-6 TGTGWAGCTTGYTCRGCTC 19 R 1703←1721 53 
pol p10 and p66/51: Protease and Reverse Transcriptase Sequences 
HIV-AK10 TYCCCACTAAYTTCTGTATRT 21 R 3316←3336 51 
HIV-AK11 GTACCAGTAAAATTAAARCCAG 22 F 2571→2592 48  
JA217 CTTTTATTTTTTCTTCTGTCAATG 24 R 2623←2646 48 
pol1D TCCCTCAAATCACTCTTTGGC 21 F 2251→2271 55  
HIV-pol 3 rev CTGAAAAATATGCATCCCCC 20 R 2882←2901 51 
HIV-PR outer3′ prot1 GCAAATACTGGAGTATTGTATGGAT
TTTCAGG 
32 R 2703←2734 59 
pol p32 Integrase Sequences 
poli5 CACACAAAGGRATTGGAGGAAATG 24 F 4162→4185 55 
poli6 ATACATATGRTGTTTTACTAARCT 24 R 5107←5130 48 
poli7 AACAAGTAGATAAATTAGTCAGT 23 F 4186→4208 48 
poli8 TAGTGGGATGTGTACTTCTGAAC 23 R 5195←5217 54 
env gp41 Transmembrane Glycoprotein Sequences 
env27_Fc CTGGYATAGTGCARCARCA 19 F 7861→7879 56 
Menv19_Rgg AARCCTCCTACTATCATTATRA 22 R 8278←8299 48 
 
2.7.1 Quality control of final sequences using the Los  
Alamos National Laboratory (LANL) HIV Sequence Databases  
Quality Control tool. 
The LANL QC tool performs a set of tests to help identify problems with HIV 
nucleotide sequences. The tests include determining subtype using the 
Recombination Identification Programme (RIP); identifying the most similar 
database sequences from HIV BLAST, constructing a phylogenetic tree for 
each sequence or all sequences using Neighbor Treemaker; determining the 
number of stop codons and frameshifts using GeneCutter; and detecting 
hypermutations using HyperMut. RIP identifies recombination in query 
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nucleotide sequences by calculating dissimilarity to a background alignment in 
a sliding window (http://www.hiv.lanl.gov/content/sequence/QC/index.html 
Accessed 22 November 2012). 
2.8 HIV analysis using online tools 
2.8.1 REGA 3.0 
The REGA HIV-1 subtyping Tool Version 3.0 
(http://bioafrica.mrc.ac.za:8080/rega-genotype-3.0.2/hiv/typingtool#/ was used 
to subtype the sequences. The REGA subtyping algorithm matches the query 
sequence with a reference alignment comprising group M subtypes A–D, F–H, 
J and K, before generating a phylogenetic tree using the HKY model of 
evolution with a gamma-distributed variation among sites. Sequences that 
cluster with particular subtypes represent non-recombinants, whereas 
sequences that do not cluster with any subtype are characterized as either 
CRFs; recombinant viruses or unclassified viral subtypes. Recombination is 
detected using bootscanning methods, and phylogenetic signal from the 
alignment is used to determine subtype. The output of the REGA analysis is a 
report comprising data for the different phylogenetic trees, the bootstrap 
support for each of the trees, as well as a graphic image of the boot-scanning 
analyses and values for the phylogenetic signal (De Oliveira et al., 2005). 
2.8.2 jpHMM  
To detect recombinants, we used the jumping profile Hidden Markov Model 
(jpHMM-HIV) tool (http://jphmm.gobics.de). This tool uses a pre-calculated 
multiple sequence alignment of the major HIV-1 subtypes to model each 
subtype in the alignment as a profile HMM. Recombination prediction for a 
query sequence involves the most probable path through the model that 
generates the sequence following state transitions within the profile HMMs, as 
well as transitions or ‘jumps’, between the different profile HMMs, at almost 
any position in the alignment. And positions of jumps between different 
subtypes define recombination breakpoints. The output report for each 
sequence comprises the predicted recombination and breakpoint intervals in 
text format, as well as a graphical representation of the predicted recombinant 
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fragments within the HIV-1 genome (Schultz, et al., 2009; Schultz, et al., 
2007)  
2.8.3 Subtype Classification Using Evolutionary Algorithms 
Subtype Classification Using Evolutionary Algorithms (SCUEAL) was used to 
test for both intra and inter recombinants in the partial HIV-1 pol and IN 
sequences (http://www.datamonkey.org/dataupload_scueal.php). SCUEAL is 
a model-based phylogenetic method for subtyping HIV-1 sequences, mapping 
the location of breakpoints and assigning parental sequences in recombinant 
strains as well as computing confidence levels for the inferred quantities. 
SCUEAL is a completely automatic method which returns a predicted subtype, 
existing CRF or a recombinant form mapped in terms of a Bayesian 
framework, and every estimated quantity including the recombinant structure, 
the location of each breakpoint and the assignment of a parental/sister lineage 
is estimated with statistical confidence to allow an objective evaluation of how 
robust the estimates are, and the algorithm runs sufficiently quickly to permit 
the screening of thousands of sequences on a computer cluster. SCUEAL 
also screens a single sequence against a fixed reference alignment. SCUEAL 
runs on the datamonkey.org platform and accepts large reference sequence 
alignments which can be easily updated when new references, for example 
CRF, become available (Delport, Poon, Frost, Kosakovsky Pond, 2010; 
Kosakovsky Pond, et al., 2009). 
2.9 Phylogenetic analysis 
2.9.1 Multiple alignments and editing of sequences. 
Multiple sequence alignments comprising the partial gag, pol and env 
sequences, and reference sequences derived from HIV-1 M group subtypes 
A-D, F-H, J-K and circulating recombinant forms obtained from the LANL 
database (http://www.hiv.lanl.gov/), was constructed using Clustal X v1.81. 
The isolate N.CM.95.YBF30.AJ006022 was used as an out-group in the 
alignments. The Clustal X multiple alignment algorithm involves calculating 
the distance matrix giving the divergence of each pair of sequence by aligning 
all pairs of sequences separately, using the resulting distance matrix to create 
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a guide using the neighbor joining method, and then aligning the sequences 
progressively according to the branching order in the guide tree (Thompson, 
Plewniak, Poch, 1999; Thompson, Gibson, Plewniak, Jeanmougin, Higgins, 
1997). Clustal imposes penalties for gaps, mismatches, as well as for 
breaking secondary structure (Egan and Crandall, unpublished). The multiple 
sequence alignments were subsequently edited manually using BioEdit v 5.09 
(Hall, 2005). 
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Table 2.11. HIV-1 subtypes A – K and CRF reference sequences from the Los 
Alamos National Laboratory HIV Sequence Database used in the construction of 
phylogenetic trees. 
Sequence 
Name 
Accession  
Number 
HIV-1 subtype/ 
group 
Location Year of  
isolation 
Reference 
Q23_17 AF004885 A1 Kenya 1994 Neilson et al., 1999 
97CDKTB48 AF286238 A2 CD 1997 Gao et al., 2001 
HXB2_LAI_IIIB_BRU K03455 B France 1983 Van Beveren et al., 1985 
1058_11 AY331295 B United States 1998 Bernardin et al., 2005 
92BR025_d U52953 C Brazil 1992 Gao et al., 1996. 
00BW0874.21 AF443090 C Botswana 2000 Novitsky et al., 2002. 
ETH2220 U46016 C Ethiopia 1986 Salminen et al., 1996. 
95IN21068 AF067155 C India 1995 Lole et al., 1999 
93MW_965 AY713413 C Malawi 1993 Brown et al., 2005 
01TZA246 AY253308 C Tanzania 2001 Arroyo et al., 2004 
04ZASK146B1 AY772699 C South Africa 2004 Rousseau et al., 2006 
02ZM110C07 AB254142 C Zambia 2002 Tatsumi et al.,unpublished 
01TZA280 AY253311 D Tanzania 2001 Arroyo et al., 2004 
93BR020_1 AF005494 F1 Brazil 1993 Gao et al., 1998 
CM53657 AF377956 F2 Cameroon 1997 Carr et al., 2001 
92NG083 U88826 G Nigeria 1992 Gao et al., 1998 
90CR056 AF005496 H CAR 1990 Gao et al., 1998 
SE7022 AF082395 J Sweden 1994 Laukkanen et al., 1999 
96CM_MP535 AJ249239 K Cameroon 1996 Triques et al., 2000 
CM240 U54771 CRF01_AE Thailand 1990 Carr et al., 1996 
04BR142 AY727527 CRF31_BC Brazil 2004 Sanabani et al., 2006 
96TZ_BF071 AF289549 CRF10_CD Tanzania 1996 Koulinska et al., 2001 
00CMNYU1162 EF087995 CRF36_cpx Cameroon 2000 Powell et al., 2007 
YBF30 AJ006022 N Cameroon 1995 Simon et al., 1998 
 
2.9.2 Neigbor Joining method using MEGA 
The phylogenetic trees for the different HIV-1 genetic fragments were 
constructed using the Neighbor-Joining method implemented in the Molecular 
Evolutionary Genetic Analysis version 5 software (MEGA v5) (Tamura, 
Peterson, Peterson, Stecher, Nei, Kumar, 2011).  
The reference sequences were derived from reference sequences from the 
LANL database (http://www.hiv.lanl.gov/) (Table 2.11).  
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After the alignments were performed and manually edited, multiple alignment 
files were imported into MEGA v 5 where the alignment files (.pir) were 
converted into a MEGA format (.meg). The MEGA files (.meg) were then 
opened in MEGA and NJ-trees (Saitou and Nei, 1987) were constructed with 
the use of the Kimura 2-parameter (Kimura, 1980). Bootstrap analysis was 
also performed on the trees to confer statistical significance, with a total of a 
1,000 bootstrap replicates for each dataset (Felsenstein, 1985). 
2.9.3 Maximum Likelihood method using MEGA 
The phylogenetic trees for the different HIV-1 genetic fragments were 
constructed using the Maximum Likelihood method implemented in the 
Molecular Evolutionary Genetic Analysis version 5 software (MEGA v5) 
(Tamura, Peterson, Peterson, Stecher, Nei, Kumar, 2011; Felsenstein, 1981). 
A General Time Reversible plus discrete Gamma distribution was used to 
model evolutionary rate differences among sites (GTR+Γ) (Tavaré, 1986; 
Yang, 1994).  
2.10 Transmitted drug resistance using CPR 
The calibrated population resistance (CPR) tool is a web-accessible program 
for performing standardized genotypic estimation of transmitted HIV-1 drug 
resistance. The program is linked to the Stanford HIV drug resistance 
database and can additionally perform viral genotyping and algorithmic 
estimation of resistance to specific antiretroviral drugs.The CPR program 
accepts FASTA-formatted HIV-1 PR and RT sequence data. A profile 
alignment of the submitted sequence set is created by aligning each 
nucleotide sequence to a polypeptide reference sequence for the region of the 
HIV-1 genome encoding PR and RT, which by default is a subtype B 
consensus sequence available from http://hivdb.stanford.edu/ .  
A list of DRMs, by default the most recent version of the SDRM list, is used to 
compute the prevalence of resistance to each of the three main classes of 
antiretroviral drug: protease inhibitors (PIs), nucleoside reverse transcriptase 
inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors 
(NNRTIs). The prevalence of transmitted HIVDR to each drug class is 
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estimated as the number of sequences containing any DRM specific to that 
drug class relative to the number of times the target gene is represented in the 
alignment. Analysis generates a report that summarizes the input data set in 
terms of drug resistance, genetic diversity, and sequence quality. The CPR 
report includes a graphical overview of DRMs and resistance-associated 
mutations present in the input dataset and a plot showing coverage across the 
target region (Gifford et al., 2009). 
CPR was used to test for transmitted drug resistance using partial HIV-1 pol 
sequences http://cpr.stanford.edu/cpr.cgi. Mutations, deletions, and insertions, 
defined as changes relative to the reference sequence, are recorded for each 
submitted sequence. The prevalence of individual mutations is calculated by 
dividing mutation frequency by the number of valid codons at the 
corresponding position in the alignment (Gifford et al., 2009). 
2.10.1 HIV drug resistance mutations using HIVdb 
HIV-1 PR and RT antiretroviral drug resistance mutations were determined 
using the Stanford University HIV Drug Resitance Database (HIVdb), 
http://www.hivdb.stanford.edu/DR/asi/releaseNotes/index.html. 
The database links sequence changes in the molecular targets of HIV-1 
therapy to other forms of data including treatment history and phenotypic, or 
drug susceptibility, data. HIVdb accepts user-submitted HIV-1 pol sequences 
and returns inferred levels of resistance to 20 FDA-approved ARV drugs 
including 8 PIs, 7 NRTIs, 4 NNRTIs, and 1 INI (Rhee, Gonzales, Kantor, 
Betts, Ravela, Shafer, 2003). 
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CHAPTER THREE 
RESULTS 
3.1. Patient cohort 
The PIME study involved 51 plasma samples that were collected from a 
patient cohort from Bushbuckridge, Mpumalanga, between February and July 
2009. The CD4+ T lymphocyte count of the samples varied between 105 cells 
and 1263 cells (Table 3.1). None of the patients were on antiretrovirals. 
3. 2. PCR amplification of partial gag, pol and env fragments. 
PCR amplification was successful for most of the Bushbuckridge, 
Mpumalanga samples, with 74.5% of the partial gag p24 gene, 54.9% of the 
partial IN p32 gene, and 83.3% of the partial env gp41 showing positive bands 
in an agarose gel after electrophoresis. However, the PCR amplification of the 
partial pol p66/p51 gene was considerably less successful at 29%. The PCR 
amplification of only one sample, that is sample 0040 or 2% of the samples, 
was negative for all sub-genomic regions (Table 3.1). Representative gels of 
the four different PCR assays are shown is Figure 3.1 to Figure 3.4.  
 
Figure 3.1. A 0.8% agarose gel analysis of the PCR amplification of the 484 bp 
fragment of the gag gene comprising a sequence that encodes the HIV-1 CA protein 
p24, and which is derived from isolates of the cohort in Mpumalanga Province. Lane 
1: 1kb DNA Ladder. 
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Table 3.1. Patient samples and PCR results (POS, Positive; –, Negative; ND, Not done). 
Patient 
Number 
CD4+ 
cell count 
Date of 
specimen 
collection 
gag p24 
PCR 
Pol 
p66/p51 
PCR 
IN p32 
PCR 
env gp41 
PCR 
0005A 466 23 April 2009 POS – POS POS 
0018A ND ND POS – POS POS 
0022A 731 24 April 2009 POS POS POS POS 
0038 680 16 March 2009 POS POS POS POS 
0039a 307 17 March 2009 POS POS POS POS 
0040A 506 23 March 2009 POS – – POS 
0040 ND 23 March 2009 – – – – 
0042A 511 19 February 2009 POS POS POS POS 
0043A ND ND – – – POS 
0055A ND ND POS POS POS POS 
0064A 105 16 March 2009 POS – – POS 
0066A 583 17 March 2009 POS – POS POS 
0073A 366 2 April 2009 POS – – POS 
0073 ND ND POS – POS POS 
0081A 437 8 April 2009 POS – – POS 
0085 154 14 April 2009 – – – POS 
0092A 137 16 April 2009 POS – POS POS 
0097A 243 17 April 2009 – – POS POS 
0098A 261 20 April 2009 POS POS – POS 
0101A 790 20 April 2009 POS POS – POS 
0103 191 20 April 2009 POS – – POS 
0116A 150 29 July 2009 POS – POS POS 
0119A 403 29 April 2009 POS POS POS POS 
0122A 262 30 April 2009 POS POS – POS 
0123A 335 4 May 2009 – – – POS 
0130A 387 6 May 2009 – – POS POS 
0132A 489 7 May 2009 POS – – POS 
0134A 792 11 May 2009 POS POS – POS 
0135A 1263 11 May 2009 POS – – POS 
0136A 1192 11 May 2009 POS POS POS POS 
0143A 353 25 May 2009 POS – POS POS 
0147A 785 27 May 2009 POS POS – POS 
0152A 691 3 June 2009 POS – – POS 
0155A ND ND – – – POS 
0165A 198 22 June 2009 POS – – POS 
0166A ND ND POS – – POS 
0173A 367 29 June 2009 POS – POS POS 
0185A 311 2 July 2009 – – POS POS 
0189 ND 20 July 2009     
0189A 560 6 July 2009 POS POS POS POS 
0190A 229 6 July 2009 POS POS – – 
0192A 522 6 July 2009 – G POS POS 
0193A 313 6 July 2009 – – POS POS 
0193 ND 6 July 2009 POS – – POS 
0198A 217 7 July 2009 – POS POS POS 
0199A 219 7 July 2009 POS – – POS 
0203A 401 8 July 2009 – POS – – 
0204A 349 28 July 2009 POS – – POS 
0206A 314 8 July 2009 – – POS – 
0207A 733 8 July 2009 POS POS POS – 
0211 312 28 July 2009 POS – – POS 
0215A 726 28 July 2009 POS – – POS 
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Figure 3.2. Agarose gel analysis of the PCR amplification of the 1085 bp fragment 
of the pol gene comprising a sequence that encodes the HIV-1 PR and RT proteins, 
p10 and p61/p51 respectively. Lane 1: 1kb DNA Ladder; lanes 2-26, patient samples. 
Lanes 8, 16, 18 and 25 were negative. 
 
 
Figure 3.3. Agarose gel analysis of the PCR amplification of the 944 bp fragment of 
the pol gene comprising a sequence that encodes the HIV-1 IN protein p32. Lane 1: 
1kb DNA Ladder, lanes 2-18, patient samples. Lanes 8, 16, 18, 25 and 26 were 
negative. 
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Figure 3.4. Agarose gel analysis of the PCR amplification of the 438 bp fragment of 
the env gene comprising a sequence that encodes the HIV-1 TM glycoprotein gp41. 
Lane 1: 1kb DNA Ladder, lanes 2-26, patient samples. Lanes 8, 16, 18, 25 and 26 
were negative. 
3.3 Sequencing data and quality control. 
Forty of the gag p24, 15 of the pol, RT/PR, 22 of the pol IN and 44 of the env 
gp41 amplicons were successfully sequenced.  
When the LANL QC tool indicated stop codons, the sequences were reread 
and verified. Hypermutation was detected in two Integrase sequences:  0130A 
and 0207A. (Detailed information is indicated in the Appendix). 
Subtypes were assigned using the RIP tool (Table 3.2). All gag sequences 
were assigned HIV-1 subtype C, except for: 0042A, 0189A, 0198A and 203.  
All pol sequences were assigned HIV-1 subtype C, except for: 00132A, 
0192A, 0198A and 204A. All env sequences were assigned HIV-1 subtype C, 
except for: 00143A and 0043A. 
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3.4 Subtype analysis using jpHMM and REGA.  
Detailed information is indicated in the Appendix. REGA and jpHMM online 
tools were used to assign subtypes to 42 gag, 14 pol p10 and p66/p51, 21 pol 
p32 and 43 env gp41 sequences. The jpHMM subtyping tool assigned 38 gag 
sequences, 13 pol sequences, 19 pol p32 sequences to subtype C, while the 
REGA subtyping tool assigned all sequences to subtype C except a single 
sequence.  
REGA detected a C, F1 intersubtype recombinant in the 0042A gag genetic 
fragment, which was discrepant from the results found in the same gag 
genetic fragment by the jpHMM subtyping tool, which is an HIV-1 subtype F2 
without any recombinant breakpoints. Significantly, the jpHMM subtyping tool 
and the RIP from the LANL QC detected recombinants in the same genetic 
fragments from the same isolates. Barring the fact that the recombinants 
detected by the the jpHMM subtyping tool and the RIP are discrepant (see 
Table 3.2 and Table 3.3) this is a remarkable instance of reproducibility by 
these subtyping and recombinant detection tools.  
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Table 3.2. Subtyping of the partial gag p24, pol p66/p51 and p32 and env gp41 
regions using RIP (–, genomic regions not subtyped). 
Sample gag p24 pol PR/RT pol p32 env gp41 
0005A C – C C 
0018A – – – C 
0022A – – – C 
0038A C – – – 
0039A C – – C 
0040A C – – C 
0042A B, C, F2, A2 C C C 
0043A – – – B 
0055A – – – C 
0064A C C C C 
0066A C – C C 
0073 – – C C 
0073A C – – C 
0081A C – C C 
0085A C C C – 
0092A C – – C 
0097A C – – C 
0098A C – C C 
0101A C – C C 
0103A C – – C 
0116A – – – – 
0119A C – – – 
0122 – – – C 
0122A C – – C 
0123A C – – C 
0130A C C C C 
0132A C C, F1 – C 
0134A C – – C 
0135A C – – – 
0136A C C C – 
0143A C C C Indeterminate 
0143A_44 – C – – 
0147A C – – C 
0152A C – – C 
0155A C – – C 
0165A C – – C 
0166A C – – C 
0173A C C C C 
0185A C – C C 
0189A A1, A2, B, C C C C 
0190A C – – C 
0192A C C C, 01_AE C 
0193A C – C C 
0193 C – – C 
0198A Indeterminate – C C 
0199A – – – C 
0203A C, D, A2, A1, AE, F2 – – C 
0204A C Indeterminate – C 
0206A C C C C 
0207A C C C C 
0211A C – – C 
0215A C – – – 
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Table 3.3. Subtyping of the partial gag p24, pol p66/p51 and p32 and env gp41 
regions using jpHMM and REGA online tools. (–, genomic regions not subtyped) 
Sample gag p24 pol p66/p51 pol p32 env gp41 
jpHMM REGA jpHMM REGA jpHMM REGA jpHMM REGA 
0005A C C – – C C C C 
0018A – – – – – – C C 
0022A – – – – – – C C 
0038A C C – – – – – – 
0039A C C – – – – C C 
0040A C C – – C C – – 
0040 – G C C – – C C 
0042A F2 C, F1 C C C C C C 
0043A – – – – – – B B 
0055A – – – – – – C C 
0064A C C C C – C C C 
0066  C – – C    
0066A C C – – C C C C 
0073 C  – – – – C C 
0073A C C – – – – C C 
0081A C C – – C C C C 
0085 C C C C C – – – 
0092A C C – – – – C C 
0097A C C – – – – C C 
0098A C C – – C C C C 
0101A C C – – C C C C 
0103A C C – – – – C C 
0116A – – – – – – – – 
0119A C  – – – – – – 
0122A B C – C – – C C 
0123A C C – – – – C C 
0130A C C C C C C C C 
0132A C C B, C C – – C C 
0134A C C – – – – C C 
0135A C C – – – – – – 
0136A – – C C C C – – 
0143A C C C C C C – C 
0147A C C – – – – C C 
0152A C C – – – – C C 
0155A – – – – – – C C 
0165A C C – – – C C C 
0173A C C C C C C C C 
0185A C C – – – C C C 
0189A G C C C C C C C 
0190A C C – – – – C C 
0192A C C C C B, C, H C C C 
0193A – – – – C, K C C C 
0193 C C – – – C – C 
0198A –  – – C C C C 
0199A C C – – – – C C 
0203A F2 C – – – – C C 
0204A C C – – – – C C 
0206A C C C C C C C C 
0207A C C C C C C C C 
0211A C C – – – – C C 
0215A C C – – – – – – 
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3.5 Subtype analysis of partial pol fragments using SCUEAL. 
The SCUEAL subtyping of the pol PR/RT and IN gene fragments revealed 
that, unlike the REGA and jpHMM subtyping tools, the PR/RT and IN 
sequences were HIV-1 subtype C (Table 3.4). Detailed information is listed in 
the APPENDIX. 
Table 3.4. jpHMM, REGA and SCUEAL subtyping of the partial pol p66/p51 and pol 
IN p32 gene fragments. (–, genomic regions not subtyped) 
Sample pol p66/p51 pol p32 
jpHMM REGA SCUEAL jpHMM REGA SCUEAL 
0005A – – C C C C 
0040 – – C C C C 
0042A C C C C C C 
0064A C C C – C C 
0066A – – – C C C 
0081A – – – C C C 
0085 C C C C – C 
0098A – – – C C C 
0101A – – – C C C 
0122A – C  – –  
0130A C C C C C C 
0132A B, C C C – – – 
0136A C C C C C C 
0143A C C C C C C 
0165A – – – – C  
0173A C C C C C C 
0185A – – – – C C 
0189A C C C C C C 
0190A – – – – – – 
0192A C C C B, C, H C C 
0193A – – – C, K C C 
0198A – – – C C C 
0206A C C C C C C 
0207A C C C C C C 
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3.6 Possible recombinant sequences detected using online tools. 
The online tools indicated some possible recombinant sequences (Table 3.2 
to Table 3.4; Figure 3.5 to Figure 3.10), but the results were not always 
supported (Appendix).  
The LANL QC graphs show similarity plots of the query sequence against 
various background sequences in an alignment in a sliding window. The the x-
axis (k) represents the query sequence position at the center of the moving 
window and the y-axis s(k) shows the similarity between that window of 
sequence and each of the background sequences. The similarity plot for 
0042A_gag shows consensus G is the sequence with the highest similarity in 
the background alignment (Figure 3.5). The two bars across the top of the 
graph represent the best match, lower bar, and the significance of the match, 
upper bar. The best match sequence is the background sequence with the 
highest similarity to the query, which in this case is consensus C.  
In Figures 3.5 – 3.10, the REGA and jpHMM graphs show maps of the HIV 
genome with the different open reading frames and the relevant genetic 
fragments with the designated HIV-1 subtypes indicated through colour 
coding. The REGA graphs show bootstrap support for the subtype, and the 
jpHMM graphs show the positions of the query sequences with respect to their 
start, end and possible breakpoints with reference to the HIV-1 HXB2 
reference sequence. 
The analysis of the gag, pol p10 and p66/p51, pol p32 and env gp41 genetic 
fragments of the isolates from Bushbuckridge, Mpumalanga using online 
quality control and subtyping tools has revealed that, while most of these 
fragments are clearly HIV-1 subtype C, a significant number may be inter-
subtype recombinants. Different genetic fragments from 0042A_gag, 
0189A_gag, 0203A_gag 0132A_pol, 0192A_IN and 0193A_IN consistently 
exhibit recombination breakpoints across all online platforms, that is, the 
LANL QC tool, jpHMM, REGA. However, SCUEAL seems to have failed to 
detect any recombination breakpoints in the genetic fragments from these 
isolates, including intra-subtype recombination, in the sequences of the 
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genetic fragments derived from these isolates. Four pol RT/PR partial 
sequences, 0042A, 0143A, 0173A, 0207A, were intra-subtype recombinants 
with breakpoints ranging from 1 to 4. And six IN partial sequences, 0040, 
0143, 0173A, 0206A, 0081A and 0098, were intra-subtype recombinants with 
breakpoints ranging from 1 to 3. The gag sub-genomic region of the 
0042A_gag, 0189A_gag, 0203A_gag isolates, the pol subgenomic region of 
the 0132A_pol isolate, and the IN sub-genomic region of the 0192A_IN 
0193A_IN isolate thus, by virtue of results from most subtyping online tools 
used in this study.  
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Figure 3.5. Possible recombinant 0042A_gag. A: LANL QC RIP detected a B, 
C, F2, A2 mosaic. B: REGA found a C, F1 recombinant. C: jpHMM found a F2 
subtype.  
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Figure 3.6. Possible recombinant 0132A_pol. A: LANL QC RIP found a C, F1 
recombinant. B: REGA found a C subtype. C: jpHMM detected a B, C recombinant. 
Stellenbosch University  http://scholar.sun.ac.za
 79 
A 
 
B 
 
 
C 
 
G 
Figure 3.7. Possible recombinant 0189A_gag. A: LANL QC detected an A1, A2, B 
and C mosaic. B: REGA found a C sutype. C: jpHMM found a G subtype.  
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Figure 3.8. Possible recombinant 0192_IN. A: LANL QC detected a C, 01_AE 
recombinant. B: REGA determined a C subtype. C: jpHMM found a B, C, H mosaic.  
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Figure 3.9 Possible recombinant 0193_IN. A: LANL QC determined a C subtype. B: 
REGA found a C subtype. C: jpHMM detected a C, K recombinant. 
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Figure 3.10. Possible Recombinant 0203A_gag. A: LANL QC found a C, D, A2, A1, 
01_AE, F2 mosaic. B: REGA found a C subtype. C: jpHMM found an F2 subtype. 
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3.7 Phylogenetc analysis using MEGA 
3.7.1 Phylogenetic trees of gag p24 
The phylogenetic tree for the gag p24 gene comprised 57 sequences, and 
was aligned using 24 references sequences from the Los Alamos National 
Laboratory HIV Sequence Database. The evolutionary history was inferred 
using the Neighbor-Joining and the Maximum Lkelihood methods. All 
sequences clustered with HIV-1 subtype C reference sequences (Figures 
3.11 and 3.12). 
3.7.2 Phylogenetic trees of pol p10 and p66/p51 
The phylogenetic tree for the pol p66/p51 gene comprised 37 sequences 
including 24 reference sequences, of which 8 were subtype C sequences. The 
evolutionary history was inferred using the Neighbor-Joining and the 
Maximum Likelihood methods. All sequences clustered with HIV-1 subtype C 
reference sequences (Figures 3.13, 3.14 and 3.15). 
3.7.3 Phylogenetic trees of pol p32 
The phylogenetic tree for the partial IN p32 contained 35 sequences, 25 
references including 8 subtype C sequences. The evolutionary history was 
inferred using the Neighbor-Joining and the Maximum Lkelihood methods. All 
sequences clustered with HIV-1 subtype C reference sequences (Figures 
3.16 and 3.17). 
3.7.4 Phylogenetic trees of env gp41 
The phylogenetic tree for the env gp41 contained 55 sequences, 24 reference 
sequences including 8 subtype C sequences. The evolutionary history was 
inferred using the Neighbor-Joining and the Maximum Lkelihood methods. All 
sequences clustered with HIV-1 subtype C reference sequences, except for 
the 0043_gp sequence that clustered with HIV-1 subtype B sequences. 
(Figures 3.18 and 3.19). 
The phylogenetic analysis of the sequences of the gag p24, pol p66/p51 IN 
p32 and env gp41 sub-genomic regions of HIV-1 isolates from Bushbuckridge 
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shows that they are all, with the exception of the 0043A_gp env gp41 
sequence, HIV-1 subtype C. While the 0132A_pol sequence doesn’t bifurcate 
in the Neighbor-Joining trees, it bifurcates in the Maximum Likelihood tree. In 
fact 0132A_pol seems almost identical to the 0207A_pol sequence in the 
Neighbor-Joining trees, which might result from from sample mix-up or 
contamination for that region. None of the recombinant sequences detected 
through the LANL QC, jpHMM and REGA subtyping online tools clustered 
with reference sequences other than subtype C during phylogenetic analysis. 
None of the sub-genomic regions supported a monophyletic South African 
lineage. The subtype C sequences from South Africa and southern African 
countries, as well as the sequence from India, all intermingle. Only sequences 
from Brazil (BR) formed country-specific cluster or monophyletic group. The 
env gp41 tree has a very distinctive branching structure with all the lineages 
splitting occurring only a short distance from the root so that the tree appears 
very ‘bottom heavy’. It is possible that such a pattern reflects a very rapid 
diversification (high birth rate) of HIV in the early stages of the AIDS epidemic 
when there were a large number of susceptible hosts and established 
networks of transmission followed by a slowing- down in the rate of 
transmission (low birth rate) due to a decline in the number of susceptible 
hosts and the long asymptomatic period of HIV infection (Holmes and Garnett, 
1994). 
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 0206A gag
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Figure 3.11 Phylogenetic tree of the HIV-1 gag p24 genomic region. The Neighbor-
Joining tree was constructed using the Kimura 2-parameter evolutionary model 
implemented in MEGA version 5. The bootstrap values of 1000 replicates above 70% 
are indicated next to the nodes and the scale bar at the bottom represents the 
number of base substitutions per site. The diamond indicates study samples. 
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 0064A gag
 0193 gag
 0152A gag
 005a gag
 0042A gag
 0134A gag
 0038A gag
 0132A gag
 0081A gag
 0207A gag
 0165A gag
 0135A gag
 0215A gag
 0039A gag
 C.IN.95IN21068
 C.ZA.04ZASK164B1
 0185A gag
 0203A gag
 0189A gag
 0097A gag
 0173A gag
 0073A gag
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 0040A gag
 0199A gag
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 B.FR.83.HXB2 LAI IIIB BRU
 B.US.1058 11
 D.TZ.01TZA280
 F1.BR.93BR020 1
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 A1.KE.Q23
 A2.CD.97CDKTB48
 G.NG.92NG083
 N.CM.YBF30
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76
61
0.05  
Figure 3.12 Phylogenetic tree of the HIV-1 gag p24 genomic region. The Maximum 
Likelihood tree was constructed using the General Time Reversible evolutionary 
model implemented in MEGA version 5, plus discrete Gamma distribution was used 
to model evolutionary rate differences among sites. The bootstrap values of 1000 
replicates above 70% are indicated next to the nodes and the scale bar at the bottom 
represents the number of base substitutions per site. The diamond indicates study 
samples. 
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 0130A pol
 0192A pol
 0085 pol
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 0042A pol
 0143A pol
 C.ET.ETH2220
 C.BR.BR025 d
 31 BC.BR.04BR142
 0040 pol
 0143A 44 pol
 C.MW.93MW 965
 C.TZ.A246
 C.IN.95IN21068
 0173A pol
 0206A pol
 C.ZM.02ZM110
 F1.BR.93BR020 1
 F2.CM.CM53657
 B.FR.83.HXB2 LAI IIIB BRU
 B.US.98.1058 11
 D.TZ.A280
 10 CD.TZ.96TZ BF071
 G.NG.92NG083
 A2.CD.97CDKTB48
 36 cpx.CM.00CMNYU1162
 A1.KE.Q23 17
 01 AE.TH.CM240
 K.CM.96.MP535
 J.SE.SE7022
 N.CM.YBF30
100
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98
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80
73
0.01  
Figure 3.13. Phylogenetic tree of the HIV-1 pol p10 and p66/p51 genomic region. 
The Neighbor-Joining tree was constructed using the Kimura 2-parameter 
evolutionary model implemented in MEGA version 5. The bootstrap values of 1000 
replicates above 70% are indicated next to the nodes and the scale bar at the bottom 
represents the number of base substitutions per site. Sequences 0207A and 0132A 
cluster together. The diamond indicates study samples. 
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Figure 3.14. Phylogenetic tree of the HIV-1 pol p10 and p66/p51 genomic region. 
The Neighbor-Joining tree was constructed using the Kimura 2-parameter 
evolutionary model implemented in MEGA version 5. The bootstrap values of 1000 
replicates above 70% are indicated next to the nodes and the scale bar at the bottom 
represents the number of base substitutions per site. The diamond indicates study 
samples. 
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 0132A pol
 0189A pol
 0130A pol
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Figure 3.15. Phylogenetic tree of the HIV-1 pol p10 and p66/p51 genomic region. 
The Maximum Likelihood tree was constructed using the General Time Reversible 
evolutionary model implemented in MEGA version 5, plus discrete Gamma 
distribution was used to model evolutionary rate differences among sites. The 
bootstrap values of 1000 replicates above 70% are indicated next to the nodes and 
the scale bar at the bottom represents the number of base substitutions per site. The 
diamond indicates study samples. 
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 0136A IN
 0193A IN
 0189A IN
 C.IN.95IN21068
 0064 IN
 C.BW.00BW087421
 0085A IN
 C.TZ.A260
 0143A IN
 0192A IN
 C.ZM.02ZM110
 C.ZA.SK164B1
 C.ET.86.ETH2220
 0040 IN
 0005A IN
 0130A IN
 C.BR.BR025 d.
 31 BC.BR.02.110PA
 C.MW.93MW 965
 0207A IN
 0042A IN
 10 CD.TZ.96TZ BF061
 B.FR.HXB2 LAI IIIB BRU.
 B.US.98.1058 11
 D.TZ.01.A280
 K.CM.96.MP535
 F1.BR.93BR020 1
 F2.CM.CM53657
 H.CF.90.056
 J.SE.SE7022
 A1.KE.Q23 17
 01 AE.TH.CM240
 A2.CD.97CDKTB48
 G.KE.HH8793 12 1
 G.NG.92NG083
 36 cpx.CM.00CMNYU1162
 N.CM.YBF30
100
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Figure 3.16. Phylogenetic tree of the HIV-1 pol p32 genomic region. The Neighbor-
Joining tree was constructed using the Kimura 2-parameter evolutionary model 
implemented in MEGA version 5. The bootstrap values of 1000 replicates above 70% 
are indicated next to the nodes and the scale bar at the bottom represents the 
number of base substitutions per site. The diamond indicates study samples. 
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 C.BW.00BW087421
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Figure 3.17 Phylogenetic tree of the HIV-1 1 pol p32 genomic region. The 
Maximum Likelihood tree was constructed using the General Time Reversible 
evolutionary model implemented in MEGA version 5, plus discrete Gamma 
distribution was used to model evolutionary rate differences among sites. The 
bootstrap values of 1000 replicates above 70% are indicated next to the nodes and 
the scale bar at the bottom represents the number of base substitutions per site. The 
diamond indicates study samples. 
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0.05  
Figure 3.18. Phylogenetic tree of the HIV-1 env gp41genomic region. The 
Neighbor-Joining tree was constructed using the Kimura 2-parameter evolutionary 
model implemented in MEGA version 5. The bootstrap values of 1000 replicates 
above 70% are indicated next to the nodes and the scale bar at the bottom 
represents the number of base substitutions per site. The diamond indicates study 
samples. 
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Figure 3.19 Phylogenetic tree of the HIV-1 env gp41genomic region. The Maximum 
Likelihood tree was constructed using the General Time Reversible evolutionary 
model implemented in MEGA version 5, plus discrete Gamma distribution was used 
to model evolutionary rate differences among sites. The bootstrap values of 1000 
replicates above 70% are indicated next to the nodes and the scale bar at the bottom 
represents the number of base substitutions per site. The diamond indicates study 
samples. 
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3.8 Transmitted drug resistance testing of the partial  
       RT/PR and IN gene using CPR 
Surveillance drug resistance mutations (SMDRs) detected in the 11 RT gene 
fragment derived from HIV-1 isolates from Bushbuckridge, Mpumalanga 
patient samples included the NRTI mutation T215S on the 0130A isolate, and 
the NNRTI mutation K103N on the 0143A isolate (Table 3.5 and Appendix). 
However, no SMDRs were detected on the 13 PR and 11 IN gene fragments 
using the calibrated population resistance CPR tool. PCR amplification was 
successful for 29% of both the partial p66/p51 and p10 genes and 54.9% of 
the IN p32 gene. While the samples may not conform to some of the World 
Health Organisation’s eligibility criteria for HIVDR surveys, including the 
requirement for the CD4+ T cells count of > 500 cells/ml, they do satisfy some 
of the criteria such as sample size and a small geographic area.  
3.8.1 Drug resistance mutations and polymorphisms  
                   detected using the HIVdb. 
Table 3.5. HIV-1 drug resistance mutations and polymorphisms against NNRTIs and 
PIs, respectively. 
Isolate Major 
PI 
Mutations 
Minor 
PI 
Mutations 
Other 
PI mutations 
NRTI 
mutations 
NNRTI 
mutations 
0040A — — M36I — — 
0042A — — M36I — — 
0064A — — M36I — — 
0085A — — M36I — — 
0130A — — M36I T215S — 
0132A — — M36I — K101Q 
0136A — — M36I — — 
0143A — — M36I — — 
0143A_44 — — M36I — K103N 
E138A 
0173A — — M36I 
T74S 
— — 
0189A — — M36I — K101E 
0192A — — M36I 
T74S 
— — 
0204A — L90R M36I — — 
0206A — — T74S — — 
0207A — — M36I — K101Q 
The T215S mutation does not decrease NRTI susceptibility but arises from 
viruses that once contained T215Y/F. The T215Y/F cause AZT and D4T 
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resistance and reduce susceptibility to ABC, ddI, and TDF. The NNRTI 
mutation K103N detected on the 0143A_44 isolate causes high-level 
resistance to NVP, and EFV. The NNRTI mutation K101Q, which was also 
detected on the the 0132A and 0207A isolates, is a relatively nonpolymorphic 
mutation that occurs slightly more commonly in patients receiving NNRTIs, 
and may contribute to reduced NVP, EFV, and ETR susceptibility when 
present with other NNRTI-resistance mutations. The NNRTI mutation, E138A, 
detected on the 0143A_44 isolate is a polymorphism that may contribute to 
reduced ETR and RPV susceptibility in combination with other NNRTI-
resistance mutations. The K101E mutation found on the 0189A isolate causes 
intermediate resistance to NVP and low-level resistance to EFV, ETR, and 
RPV. Except for the L90R minor PI mutation detected on the 0204A isolate, 
no major or minor PI mutations were detected in the Bushbuckridge, 
Mpumalanga isolates. The L90M mutation reduces susceptibility to NFV, 
SQV/r, ATV/r, and IDV/r when present with other mutations. One of the most 
common mutations, M36I, a consensus amino acid in most non-B subtypes, is 
weakly associated with PI resistance in subtype B viruses when present with 
other mutations. The T74S mutation occurs in about 5% of untreated persons 
with subtype C viruses and is associated with reduced NFV susceptibility 
(Barth et al., 2008; Cane et al., 2001; Soares et al., 2009; Velasquez-Campoy 
et al., 2001).  
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CHAPTER FOUR 
DISCUSSION AND CONCLUSIONS 
4. 1. Discussion 
The investigation of the HIV subtype diversity of samples obtained from a 
cohort in Bushbuckridge, Mpumalanga revealed, first, that the HIV from these 
samples belong almost entirely to HIV-1 subtype C; second, that the way in 
which the sequences derived from these samples cluster in phylogenetic trees 
suggests there has been multiple introductions of HIV into Bushbuckridge; 
and third, the prevalence of SDRMs, as well as antiretroviral drug resistance 
mutations and drug resistance-associated polymorphisms, in Bushbuckridge 
is extremely low.  
4.1.1 Bushbuckridge HIV epidemic is predominantly  
            subtype C. 
Phylogenetic analysis revealed that the partial sub-genomic gag p24, pol p10 
and p66/p51, pol p32 and env gp41 sequences derived from patients from 
Bushbuckridge, Mpumalanga, belong to HIV-1 subtype C. The 
Bushbuckridge, Mpumalanga sequences almost invariably clustered with HIV-
1 subtype C reference sequences from South Africa. Botswana, Malawi, 
Zambia, India, Ethiopia and Brazil in both NJ and ML trees constructed using 
MEGA. The only sequence that clustered with HIV-1 subtype B sequences 
was env gp41 0043A_gp. However, the PCR amplification of the gag p24, pol 
p10 and p66/p51, pol p32 genomic regions of the 0043A sample were not 
successful, which implies they may not necessarily have clustered with HIV-1 
subtype B sequences, and that the 0043A sample could have been a 
recombinant. 
The HIV-1 subtyping of the gag p24, pol p10 and p66/p51, pol p32 and env 
gp41 sequences using the LANL QC RIP tool, jpHMM and REGA, as well as 
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subtyping using SCUEAL for pol sequences, revealed that most of the 
Bushbuckridge, Mpumalanga isolates belonged to subtype C. Subtype 
analysis of the Bushbuckridge sequences using jpHMM and REGA subtyping 
tools also detected recombination between sequence segments from different 
HIV-1 subtypes within single subgenomic fragments in the 0042A_gag, 
0132A_pol, 0189A_gag, 0192A_IN, 0193A_IN and 0203_gag sequences. 
The fact that the HIV samples from Bushbuckridge, Mpumalanga, belong 
almost entirely to subtype C is consistent not only with the explosive HIV-1 
epidemic in southern Africa, but also it’s very limited subtype diversity. HIV-1 
subtype C is the most common subtype, accounting for 92% of HIV infections 
in southern Africa, while subtype B is responsible for about 7% of infections. 
(Butler et al., 2007; Bredell., et al., 1998; Bredell et al., 2000; Bredell et al., 
2002; Morris et al., 2000; Novitsky et al., 1999; Van Harmelen et al.; 
Williamson et al.; UNAIDS, 2012). 
4.1.2 Multiple introductions of HIV into Bushbuckridge. 
Significantly, the Bushbuckridge isolates do not only cluster with the 
SouthAfrican HIV-1 subtype C isolate in both the NJ and ML phylogenetic 
trees, but also cluster and intermingle with the radiation comprising HIV-1 
subtype C isolates from Botswana, Malawi, Zambia, as well as India. That is 
the sequences from South Africa and southern African countries, as well as 
the one from India (IN), do not exhibit country-specific clusters and instead 
show a spread of the sequences throughout the tree indicating multiple 
introductions of subtype C viruses in these countries. The fact that HIV-1 
subtype C sequences from South Africa tend to intermingle with HIV-1 
subtype C sequences from Botswana, Malawi and Zambia suggests they may 
have a common evolutionary origin. The possibility of an underlying common 
evolutionary origin of isolates in southern Africa is consistent with the history 
of the population dynamics of the southern African region. While the HIV-1 
subtype C isolates from Brazil and Ethiopia tend to cluster separately, the fact 
that the subtype C isolate from India tends to cluster with the subtype C 
isolates from southern Africa can be explained by the historical connections 
between the Indian subcontinent and southern Africa arising from the roles of 
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both regions as former British colonial territories. Thus, there may be 
continuing movement of the virus between Africa and India. As a 
consequence, a strain like IN101 (accession number AB023804) from India is 
closer to most African subtype C strains than African strains are to each other 
(Gaschen et al., 2002; Shankarappa et al., 2001). 
One of the central elements of the population dynamics of not only South 
Africa but the broader southern African region, critical in shaping the patterns 
of population mobility and integration characterizing the region, was 
indubitably the migrant labour sytem. The migrant labour system, which linked 
countries in southern Africa in which adult national HIV prevalence exceeded 
15% in 2007, was integral to the development and structure of the South 
African economy and apartheid. Botswana, Lesotho, Namibia, South Africa, 
Swaziland, Zambia, and Zimbabwe, were historically linked through the 
migrant labour system that brought men from as far as Zambia and Malawi to 
the mines initially on the Reef and subsequently elsewhere in the country 
(Abdool Karim and Abdool Karim, 2002; Bauer and Taylor, 2005; Dusheiko et 
al., 1989; Huang et al., 2009).). Migrants are more vulnerable to HIV infection 
than are people who do not move, both in southern Africa as in other African 
countries (Abdool Karim, 1992; Decosas, 1995; Lurie, 2001). A 1985 survey of 
workers in the gold mines from the whole southern African region showed HIV 
to be rare in South African miners but already at 3% prevalence in Malawians 
(Abdool Karim and Abdool Karim, 2002). High infection levels are being found 
in Gaza province in Mozambique, where large numbers of migrants working in 
South Africa originate (Ministry of Health, Mozambique, 2005). Before and 
after independence foreign migrant workers also crossed borders to work in 
mines in Namibia, Botswana, Zambia, and Zimbabwe (Bauer and Taylor, 
2005; Lurie, 2000; Lurie et al., 2003).  
The fact that many of the southern African countries with the explosive 
HIV/AIDS epidemic are landlocked entails that the region’s road transport 
networks does not just link these landlocked countries to the ports in Durban, 
Richards Bay and Maputo, but also facilitate the rapid spread of HIV in the 
region by ensuring the sexual networks that drive the epidemic transcend 
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national boundaries. The Ehlanzeni District in Mpumalanga Province straddles 
the Maputo Corridor, a major trade route which connects the Gauteng, 
Limpopo, and Mpumalanga provinces of South Africa with Maputo, the capital 
of Mozambique that also has a major port. In Mozambique, HIV is spreading 
more rapidly in provinces linked by major transport routes to Malawi, South 
Africa and Zimbabwe. High infection rates have been found in Sofala 
province, which is traversed by Zimbabwe’s main export route (Mozambique, 
2005; Ramjee and Gouws, 2002). 
The peculiarly explosive HIV-1 epidemic in southern Africa could also stem 
from the unique biological properties of subtype C.HIV-1 subtype C has an 
additional NF-κB binding site in the long terminal repeat (LTR), a prematurely 
truncated Rev protein, a 5′-amino-acid insertion in Vpu, and a more active, 
catalytically efficient protease, which may influence viral gene expression and 
alter the transmissibility and pathogenesis of subtype C isolates (De Oliveira 
et al., 2003; Gao et al., 1998; Hunt and Tiemessen, 2000; McCormick-Davis 
et al., 2000; Rodenburg et al., 2001; Valesquez-Campoy et al., 2001). These 
unique biological properties, including those related to viral entry and 
pathogenesis such as the CCR5 and non-syncytium-inducing phenotype, may 
account for the explosive epidemic of HIV-1 subtype C in southern Africa (Ball 
et al., 2003; Peeters et al., 1999; Ping et al., 1999). However, the additional 
NF-κB site in HIV-1 subtype C may be biologically inactive, and enhanced 
activity of these individual functions may still not be sufficient to overcome the 
decreased replicative capacity of the CCR5-tropic non-syncytium-inducing 
phenotype (Ball et al., 2003). 
4.1.3 SMDRs, resistance mutations and polymorphisms  
                in the cohort. 
Two SMDRs, T215S and K103N detected on the 0130A and 0143_44 isolates 
respectively, were also found on the same isolates using the Stanford 
University Drug Resistance Database. The T215S and K103N mutations 
suggest the patients may either have undergone antiretroviral treatment or 
been infected with antiretroviral drug resistant strains (Barth et al., 2008; Cane 
et al., 2001; Soares et al., 2009; Velasquez-Campoy et al., 2001).  
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4.1.4 Limitations of the study. 
The limitations of the study include a relatively small sample size; DNA 
amplification was not successful for up to 71% of the samples of, for example, 
the partial pol p10 and p66/p51 sub-genomic region; use of partial gene 
regions to assign viral subtypes, potentially allowing recombinant viruses to be 
missed, the use of direct; population sequencing may result in the lack of 
detection of minority-population viruses; which can lead to an underestimation 
of viral diversity and drug resistance mutations (Iweriebor et al., 2012). 
4.2. Conclusions 
HIV diversity may have implications for diagnosis, pathogenesis, transmission, 
clinical management and vaccine development. Phylogenetic analysis of HIV 
sequence diversity has allowed vital insights into the origin, evolution and 
spread of HIV, which suggests it is imperative to maintain HIV molecular 
epidemiology surveillance. Molecular epidemiological investigations in South 
Africa have, with the notable exceptions of the Free State and Limpopo, 
largely focused on provinces with major metropolitan centers such as 
Guateng, the Western Cape and KwaZulu Natal. Hardly any molecular 
epidemiological studies have been undertaken in the Eastern Cape, 
Mpumalanga, North West and Northern Cape provinces. The extensive 
population mobility arising from the historical and structural migrant labour 
system characterizing South Africa, and the concomitant overlapping of 
sexual networks, seems to have precluded the possibility of distinct 
geographical lineages developing. However, the demise of apartheid, in 
particular the end of influx control measures, may have a significant impact on 
patterns of population mobility and settlement in South Africa, which in turn 
may affect the patterns of transmission of HIV and ultimately it’s evolution. 
The possible emergence of various HIV-1 recombinants could suggest that 
the migration of people into South Africa from Central, West and eastern 
Africa could also impact on the character and dynamics of the HIV/AIDS 
epidemic in South Africa (Engelbrecht et al., 1999). 
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Table 1. LANL QC results of the gag sequences 
SeqName Blast Subtype StopCodons Frameshifts 
005a_gag FJ198524|ZA|C|96 C 0 1 
0038A_gag JN014194|ZM|C|96 C 0 1 
0039A_gag FJ198843|ZA|C|96 C 0 2 
0040A_gag GU017793|UG|C|96 C 0 1 
0042A_gag HQ423975|ZA|C|96 B,C,F2,A2 0 1 
0064A_gag AF543954|ZA|C|96 C 0 2 
0066A_gag AY255819|IL|C|96 C 0 1 
0073A_gag FJ198849|ZA|C|96 C 0 2 
0081A_gag FJ198691|ZA|C|98 C 0 1 
0085A_gag FJ198491|ZA|C|95 C 0 0 
0092A_gag FJ198550|ZA|C|97 C 0 1 
0097A_gag FJ198629|ZA|C|98 C 0 2 
0098A_gag AF543968|ZA|C|96 C 0 2 
0101A_gag DQ093605|ZA|C|95 C 0 1 
0103A_gag FJ199034|ZA|C|97 C 0 1 
0119A_gag FJ606422|ZM|C|94 C 0 1 
0122A_gag EU698192|ZA|C|93 C 0 1 
0123A_gag FJ198849|ZA|C|97 C 0 2 
0130A_gag JN167458|ZA|C|98 C 0 1 
0132A_gag FJ606162|ZM|C|97 C 0 0 
0134A_gag AF543951|ZA|C|97 C 0 1 
0135A_gag DQ792993|ZW|C|97 C 0 1 
0143A_gag HM593145|ZA|C|95 C 0 1 
0147A_gag JN167458|ZA|C|98 C 0 2 
0152A_gag EU698363|ZA|C|97 C 1 2 
0165A_gag FJ198508|ZA|C|98 C 1 2 
0173A_gag FJ198629|ZA|C|98 C 0 2 
0185A_gag EU698192|ZA|C|97 C 1 2 
0189A_gag AY838592|ZA|C|97 A1,A2,B,C 0 2 
0190A_gag AF543954|ZA|C|97 C 0 2 
0192A_gag FJ199034|ZA|C|97 C 1 0 
0193_gag FJ198599|ZA|C|97 C 0 2 
0198A_gag EF178402|AU|B|89 Cannot 
determine 
0 0 
0199A_gag FJ497890|BW|C|97 C 0 2 
0203A_gag FJ198571|ZA|C|98 C,D,A2,01_AE,F2 0 2 
0204A_gag GU201724|ZA|C|96 C 0 1 
0206A_gag AY713416|SN|C|97 C 0 1 
0207A_gag AF543968|ZA|C|96 C 0 1 
0211A_gag DQ093599|ZA|C|96 C 0 1 
0215A_gag FJ198831|ZA|C|98 C 0 2 
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Table 2. LANL QC results of the pol (PR and RT) sequences 
 
 
Table 3. LANL QC results of the pol IN sequences 
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Table 4. LANL QC results of the env sequences 
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Table 5. REGA v 3.0 results of the gag sequences 
Name 
Length 
bp Subtype assignment Support Begin End 
005a_gag 458 HIV-1 Subtype C 98 1248 1706 
0038A_gag 459 HIV-1 Subtype C 100 1252 1711 
0039A_gag 454 HIV-1 Subtype C 95 1252 1706 
0040A_gag 458 HIV-1 Subtype C 96 1248 1706 
0042A_gag 846 Recombinant of C, F1  861 1707 
0064A_gag 455 HIV-1 Subtype C 98 1253 1708 
0066A_gag 456 HIV-1 Subtype C 98 1251 1707 
0073A_gag 454 HIV-1 Subtype C 99 1252 1706 
0081A_gag 452 HIV-1 Subtype C 100 1249 1701 
0085A_gag 481 HIV-1 Subtype C 100 1248 1729 
0092A_gag 455 HIV-1 Subtype C 100 1251 1706 
0097A_gag 459 HIV-1 Subtype C 99 1247 1706 
0098A_gag 457 HIV-1 Subtype C 100 1249 1706 
0101A_gag 458 HIV-1 Subtype C 96 1248 1706 
0103A_gag 456 HIV-1 Subtype C 98 1250 1706 
0119A_gag 458 Check the report  1248 1706 
0122A_gag 425 HIV-1 Subtype C 98 1248 1673 
0123A_gag 457 HIV-1 Subtype C 99 1249 1706 
0130A_gag 459 HIV-1 Subtype C 98 1248 1707 
0132A_gag 484 HIV-1 Subtype C 99 1248 1732 
0134A_gag 458 HIV-1 Subtype C 99 1248 1706 
0135A_gag 458 HIV-1 Subtype C 100 1251 1709 
0143A_gag 482 HIV-1 Subtype C 93 1248 1730 
0147A_gag 467 HIV-1 Subtype C 100 1240 1707 
0152A_gag 462 HIV-1 Subtype C 98 1249 1711 
0165A_gag 459 HIV-1 Subtype C 96 1248 1706 
0173A_gag 460 HIV-1 Subtype C 100 1246 1706 
0185A_gag 457 HIV-1 Subtype C 100 1251 1706 
0189A_gag 882 
Subtype C, potential 
recombinant 94 826 1708 
0190A_gag 455 HIV-1 Subtype C 98 1252 1707 
0192A_gag 456 HIV-1 Subtype C 98 1251 1706 
0193_gag 456 HIV-1 Subtype C 98 1250 1706 
0198A_gag 458 Check the report  1250 1708 
0199A_gag 459 HIV-1 Subtype C 100 1249 1708 
0203A_gag 863 HIV-1 Subtype C 94 843 1706 
0204A_gag 464 HIV-1 Subtype C 99 1245 1709 
0206A_gag 424 HIV-1 Subtype C 91 1284 1708 
0207A_gag 458 HIV-1 Subtype C 97 1248 1706 
0211A_gag 458 HIV-1 Subtype C 100 1248 1706 
0215A_gag 456 HIV-1 Subtype C 100 1250 1706 
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Table 6. REGA v 3.0 results of the pol (PR and RT) sequences 
Name 
Length 
bp Subtype assignment Support Begin End 
0040_pol 1215 HIV-1 Subtype C 100 2108 3335 
0042A_pol 1215 HIV-1 Subtype C 100 2111 3335 
0064A_pol 1209 HIV-1 Subtype C 100 2132 3339 
0085_pol 1204 HIV-1 Subtype C 100 2131 3340 
0130A_pol 1201 HIV-1 Subtype C 100 2132 3339 
0132A_pol 1319 HIV-1 Subtype C 100 2132 3460 
0136A_pol 1189 HIV-1 Subtype C 100 2131 3335 
0143A_pol 1181 HIV-1 Subtype C 100 2142 3335 
0143A_44_pol 1216 HIV-1 Subtype C 100 2112 3340 
0173A_pol 1206 HIV-1 Subtype C 100 2124 3335 
0189A_pol 711 HIV-1 Subtype C 100 2132 2855 
0192A_pol 625 HIV-1 Subtype C 100 2134 2771 
0204A_pol 351 Check the report  2177 2534 
0206A_pol 1202 HIV-1 Subtype C 100 2113 3330 
0207A_pol 1196 HIV-1 Subtype C 100 2133 3341 
 
Table 7. REGA v 3.0 results of the pol IN gag sequences 
Name 
Length 
bp Subtype assignment Support Begin End 
0005A_IN 878 HIV-1 Subtype C 100 4206 5084 
0040_IN 907 HIV-1 Subtype C 100 4207 5114 
0042A_IN 910 HIV-1 Subtype C 100 4203 5113 
0064A_IN 908 HIV-1 Subtype C 100 4203 5111 
0085A_IN 903 HIV-1 Subtype C 100 4201 5104 
0130A_IN 915 HIV-1 Subtype C 100 4200 5115 
0136A_IN 983 HIV-1 Subtype C 100 4207 5190 
0143A_1_IN 890 HIV-1 Subtype C 100 4213 5103 
0143A_2_IN 880 HIV-1 Subtype C 100 4203 5083 
0173A_IN 884 HIV-1 Subtype C 100 4213 5097 
0189A_IN 900 HIV-1 Subtype C 100 4208 5108 
0192A_IN 895 HIV-1 Subtype C 100 4206 5102 
0206A_IN 892 HIV-1 Subtype C 100 4208 5100 
0207A_IN 906 HIV-1 Subtype C 100 4207 5113 
0066A_IN 871 HIV-1 Subtype C 100 4211 5082 
0081A_IN 868 HIV-1 Subtype C 100 4229 5097 
0098A_IN 849 HIV-1 Subtype C 100 4235 5084 
0101A_IN 860 HIV-1 Subtype C 100 4247 5107 
0185A_IN 875 HIV-1 Subtype C 100 4223 5098 
0192A_IN 866 HIV-1 Subtype C 100 4229 5095 
0193A_IN 780 HIV-1 Subtype C 100 4226 5006 
0198A_IN 817 HIV-1 Subtype C 100 4226 5043 
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Table 8. REGA v 3.0 results of the env sequences 
Name 
Length 
bp 
Subtype 
assignment Support Begin End 
0005_gp 408 HIV-1 Subtype C 99 7875 8283 
0018A_gp 399 HIV-1 Subtype C 100 7881 8280 
0022A_gp 424 HIV-1 Subtype C 100 7872 8296 
0039A_gp 421 HIV-1 Subtype C 100 7875 8296 
0040_gp 404 HIV-1 Subtype C 100 7878 8282 
0042A_gp 408 HIV-1 Subtype C 100 7875 8283 
0043A_gp 400 HIV-1 Subtype B 92 7895 8284 
0055A_gp 411 HIV-1 Subtype C 99 7875 8286 
0064A_gp 373 HIV-1 Subtype C 100 7914 8287 
0066A_gp 409 HIV-1 Subtype C 99 7878 8287 
0073_gp 422 HIV-1 Subtype C 100 7872 8294 
0073A_gp 410 HIV-1 Subtype C 100 7878 8288 
0081A_gp 410 HIV-1 Subtype C 100 7875 8285 
0092A_gp 409 HIV-1 Subtype C 100 7875 8284 
0097A_gp 409 HIV-1 Subtype C 99 7875 8284 
0098A_gp 409 HIV-1 Subtype C 100 7875 8284 
0101A_gp 406 HIV-1 Subtype C 100 7878 8284 
0103A_gp 410 HIV-1 Subtype C 99 7875 8285 
0122_gp 439 HIV-1 Subtype C 99 7863 8302 
0123A_gp 359 HIV-1 Subtype C 100 7925 8286 
0130A_gp 409 HIV-1 Subtype C 100 7875 8284 
0132A_gp 405 HIV-1 Subtype C 100 7878 8283 
0134A_gp 408 HIV-1 Subtype C 100 7875 8283 
0143A 386 Check the report  7867 8241 
0147_gp 409 HIV-1 Subtype C 100 7875 8284 
0152A_gp 409 HIV-1 Subtype C 100 7875 8284 
0155A_gp 408 HIV-1 Subtype C 100 7875 8283 
0165A_gp 408 HIV-1 Subtype C 100 7875 8283 
0173A_gp 400 HIV-1 Subtype C 100 7875 8275 
0185A_gp 413 HIV-1 Subtype C 100 7875 8288 
0189_gp 370 HIV-1 Subtype C 96 7914 8284 
0190A_gp 406 HIV-1 Subtype C 100 7878 8284 
0192A_gp 408 HIV-1 Subtype C 100 7875 8283 
0193_gp 422 HIV-1 Subtype C 100 7862 8284 
0193A_gp 408 HIV-1 Subtype C 97 7875 8283 
0198A_gp_1 405 HIV-1 Subtype C 100 7878 8283 
0198A_gp_2 393 HIV-1 Subtype C 100 7890 8283 
0199A_gp_2 409 HIV-1 Subtype C 99 7875 8284 
0199A_gp_1 406 HIV-1 Subtype C 99 7878 8284 
0203A_gp 405 HIV-1 Subtype C 98 7878 8283 
0204A_gp 412 HIV-1 Subtype C 100 7872 8284 
0206A_gp 408 HIV-1 Subtype C 99 7875 8283 
0207_gp 406 HIV-1 Subtype C 99 7878 8284 
0211_gp 409 HIV-1 Subtype C 100 7875 8284 
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Table 9. SQUEAL results of the pol (PR and RT) sequences 
 
 
 
Name Subtype Expanded subtype 
Confidence 
in 
Assignment 
Support for 
recombination 
Support for intra-
subtype 
recombination 
Breakpoints 
0040_pol C C 0.764177 0.235823 0.235816  
0042A_pol C C intra-subtype recombinant (2 breakpoints) 0.556369 0.996056 0.995983 
819(817-821); 
944(941-947) 
0064A_pol C C 0.927817 0.0721828 0.0721729  
0085_pol C C 0.999544 0.000456014 0.000456014  
0130A_pol C C 0.835575 0.164425 0.0509365  
0132A_pol C,CPZ  C,C,C,CPZ inter-subtype recombinant 0.632129 1 0.000211618 
101(1-492); 
499(498-500); 
1094(1093-1095) 
0136A_pol C C 0.999801 0.000199417 0.000199417  
0143A_pol C C intra-subtype recombinant (4 breakpoints) 0.50413 0.999791 0.997879 
101(50-152); 
643(642-644); 
814(813-815); 
956(955-957) 
0143A_44_pol C C 0.99996 4.05E-05 4.05E-05  
0173A_pol C C intra-subtype recombinant (1 breakpoints) 0.664622 0.79679 0.796765 316(232-400) 
0189A_pol C C 0.695241 0.304759 0.304759  
0192A_pol C C 0.940919 0.0590808 0.0590808  
0206A_pol C C 0.673925 0.326075 0.326074  
0207A_pol C C intra-subtype recombinant (2 breakpoints) 0.786224 0.790867 0.790866 
110(109-111); 
284(271-297) 
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Table 10. SQUEAL results of the pol (IN) sequences 
Name Expanded subtype Confidence in Assignment 
Support for 
recombination 
Support for 
intra-subtype 
recombination 
Breakpoints 
0005A_IN C 0.992215 0.00778526 0.00778526  
0040_IN 
C intra-subtype 
recombinant (1 
breakpoints) 
0.724519 0.758161 0.758152 555(466-644) 
0042A_IN C 0.994517 0.00548278 0.00548278  
0064A_IN C 0.609436 0.390564 0.390389  
0085A_IN C 0.999718 0.000281964 0.000281964  
0130A_IN C 0.646731 0.353268 0.353268  
0136A_IN C 0.799613 0.200387 0.200384  
0143A_1_IN 
C intra-subtype 
recombinant (2 
breakpoints) 
0.807617 0.967812 0.967722 101(97-105); 249(237-261) 
0143A_2_IN C 0.999955 4.53E-05 4.53E-05  
0173A_IN 
C intra-subtype 
recombinant (2 
breakpoints) 
0.662959 0.679639 0.679073 267(258-276); 564(562-566) 
0189A_IN C 0.999969 3.11E-05 2.46E-05  
0192A_IN 
C intra-subtype 
recombinant (3 
breakpoints) 
0.557236 0.999569 0.981578 
265(262-268); 
409(408-410); 
774(773-775) 
0206A_IN 
C intra-subtype 
recombinant (1 
breakpoints) 
0.614465 0.675081 0.675066 784(778-790) 
0207A_IN C 0.998927 0.00107285 0.00107272  
0066A_IN C 0.970445 0.0295545 0.0295545  
0081A_IN 
C intra-subtype 
recombinant (2 
breakpoints) 
0.533426 0.599499 0.59949 408(402-414); 637(622-652) 
0098A_IN 
C intra-subtype 
recombinant (3 
breakpoints) 
0.86141 0.999989 0.999773 
172(171-173) 
383(382-384); 
736(714-758) 
0101A_IN C 0.997377 0.00262261 0.00262261  
0185A_IN C 0.999237 0.000762537 0.000762537  
0192A_IN C 0.861912 0.138088 0.138088  
0193A_IN C 0.997888 0.00211194 0.00211194  
0198A_IN C 0.991374 0.00862639 0.00847651  
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Table 11. SDRM results of the pol sequences 
Number of input sequences 
 
No. 
submitted 
No. filtered 
(QA)* No. analyzed for SDRMs 
Sequences 15   
Sequences containing either RT or 
PR 15 1 14 
Sequences containing RT 13 1 12 
Sequences containing PR 15 1 14 
Sequences containing both RT and 
PR 13 1 12 
Proportion of sequences  
with SDRMs 
Resistance category 
No. 
analyzed 
No. 
containing 
SDRM % 
Sequences with any SDRM 14 2 14.3 
PR Sequences with any PI SDRM 14 0 0 
RT Sequences with any NRTI 
SDRM 12 1 8.3 
RT Sequences with any NNRTI 
SDRM 12 1 8.3 
RT Sequences with any NRTI + any 
NNRTI SDRM 12 0 0 
PRRT Sequences with any NRTI + 
any NNRTI + PI SDRM 12 0 0 
Sequences with SDRMs 
SequenceID 
NRTI 
SDRMs 
NNRTI 
SDRMs PI SDRMs 
0130A_pol T215S None None 
0143A_44_pol None K103N None 
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